-
1
-
-
36749073295
-
Privileged structures and analogue-based drug discovery
-
Fischer, J.; Ganellin, C.R., Eds.; Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim
-
Kubinyi, H. Privileged Structures and Analogue-Based Drug Discovery. In: Analogue-Based Drug Discovery; Fischer, J.; Ganellin, C.R., Eds.; Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim, 2006; pp. 53-68.
-
(2006)
Analogue-Based Drug Discovery
, pp. 53-68
-
-
Kubinyi, H.1
-
2
-
-
79961000327
-
Ligand specificity, privileged substructures and protein druggability from fragment-based screening
-
Barelier, S.; Krimm, I. Ligand specificity, privileged substructures and protein druggability from fragment-based screening. Curr. Opin. Chem. Biol., 2011, 15, 469-474.
-
(2011)
Curr. Opin. Chem. Biol.
, vol.15
, pp. 469-474
-
-
Barelier, S.1
Krimm, I.2
-
3
-
-
54949134905
-
Chemical substructures that enrich for biological activity
-
Klekota, J.; Lundell, G. Chemical substructures that enrich for biological activity. Bioinformatics, 2008, 24, 2518-2525.
-
(2008)
Bioinformatics
, vol.24
, pp. 2518-2525
-
-
Klekota, J.1
Lundell, G.2
-
4
-
-
21244498671
-
The top pharmaceuticals that changed the world
-
Baum, R.M. The top pharmaceuticals that changed the world. Chem. Eng. News, 2005, 83, p 5.
-
(2005)
Chem. Eng. News
, vol.83
, pp. 5
-
-
Baum, R.M.1
-
5
-
-
13744254730
-
The composition of Ehrlich's Salvarsan: Resolution of a century-old debate
-
DOI 10.1002/anie.200461471
-
Lloyd, N.C.; Morgan, H.; W. Nicholson, B.K.; Ronimus, R.S. The composition of Ehrlich's salvarsan: resolution of a century-old debate. Angew. Chem. Int. Ed. Engl., 2005, 44, 941-944. (Pubitemid 40239026)
-
(2005)
Angewandte Chemie - International Edition
, vol.44
, Issue.6
, pp. 941-944
-
-
Lloyd, N.C.1
Morgan, H.W.2
Nicholson, B.K.3
Ronimus, R.S.4
-
6
-
-
84860510666
-
Further progress in chemotherapy of bacterial infections
-
Nobel Lecture, December 12, 1947; Elsevier Publishing Company: Amsterdam
-
Domagk, G. Further progress in chemotherapy of bacterial infections. In: Nobel Lectures, Physiology or Medicine 1922-1941, Nobel Lecture, December 12, 1947; Elsevier Publishing Company: Amsterdam, 1965; pp. 490-527.
-
Nobel Lectures, Physiology or Medicine 1922-1941
, vol.1965
, pp. 490-527
-
-
Domagk, G.1
-
7
-
-
27844501228
-
Architecture and evolution of organic chemistry
-
DOI 10.1002/anie.200502272
-
Fialkowski, M.; Bishop, K.J.M.; Chubukov, V.A.; Campbell, C.J.; Grzybowski, B.A. Architecture and evolution of organic chemistry. Angew. Chem. Int. Ed. Engl., 2005, 44, 7263-7269. (Pubitemid 41641747)
-
(2005)
Angewandte Chemie - International Edition
, vol.44
, Issue.44
, pp. 7263-7269
-
-
Fialkowski, M.1
Bishop, K.J.M.2
Chubukov, V.A.3
Campbell, C.J.4
Grzybowski, B.A.5
-
8
-
-
67949084937
-
The "wired" universe of organic chemistry
-
Grzybowski, B.A.; Bishop, K.J.M.; Kowalczyk, B.; Wilmer, C.E. The "wired" universe of organic chemistry. Nat. Chem., 2009, 1, 31-36.
-
(2009)
Nat. Chem.
, vol.1
, pp. 31-36
-
-
Grzybowski, B.A.1
Bishop, K.J.M.2
Kowalczyk, B.3
Wilmer, C.E.4
-
9
-
-
34249328535
-
Does drug-target have a likeness?
-
DOI 10.1160/ME0425
-
Chen, X.; Fang, Y.; Yao, L.; Chen, Y.; Xu, H. Does drug-target have a likeness? Methods Inf. Med., 2007, 46, 360-366. (Pubitemid 46807209)
-
(2007)
Methods of Information in Medicine
, vol.46
, Issue.3
, pp. 360-366
-
-
Xu, H.1
Fang, Y.2
Yao, L.3
Chen, Y.4
Chen, X.5
-
10
-
-
34547265045
-
Properties and architecture of drugs and natural products revisited
-
Grabowski, K.; Schneider, G. Properties and architecture of drugs and natural products revisited. Curr. Chem. Biol., 2007, 1, 115-127.
-
(2007)
Curr. Chem. Biol.
, vol.1
, pp. 115-127
-
-
Grabowski, K.1
Schneider, G.2
-
11
-
-
0029894013
-
The properties of known drugs. 1. Molecular frameworks
-
DOI 10.1021/jm9602928
-
Bemis, G.W.; Murcko, M.A. The properties of known drugs. 1. Molecular frameworks. J. Med. Chem., 1996, 39, 2887-2893. (Pubitemid 26251026)
-
(1996)
Journal of Medicinal Chemistry
, vol.39
, Issue.15
, pp. 2887-2893
-
-
Bemis, G.W.1
Murcko, M.A.2
-
12
-
-
0033576605
-
Properties of known drugs. 2. Side chains
-
DOI 10.1021/jm9903996
-
Bemis, G.W.; Murcko, M.A. Properties of known drugs. 2. Side chains. J. Med. Chem., 1999, 42, 5095-5099. (Pubitemid 30020260)
-
(1999)
Journal of Medicinal Chemistry
, vol.42
, Issue.25
, pp. 5095-5099
-
-
Bemis, G.W.1
Murcko, M.A.2
-
13
-
-
77954331609
-
Scaffold explorer: An interactive tool for organizing and mining structure-activity data spanning multiple chemotypes
-
Agrafiotis, D.K.; Wiener, J.J. Scaffold explorer: an interactive tool for organizing and mining structure-activity data spanning multiple chemotypes. J. Med. Chem., 2010, 53, 5002-5011.
-
(2010)
J. Med. Chem.
, vol.53
, pp. 5002-5011
-
-
Agrafiotis, D.K.1
Wiener, J.J.2
-
14
-
-
79955386295
-
Screening informatics
-
Chen, T., Ed.; CRC Press
-
Schurer, S.; Tsinoremas, N. Screening Informatics. In: A Practical Guide to Assay Development and High-Throughput Screening in Drug Discovery; Chen, T., Ed.; CRC Press, 2009; pp. 233-263.
-
(2009)
A Practical Guide to Assay Development and High-Throughput Screening in Drug Discovery
, pp. 233-263
-
-
Schurer, S.1
Tsinoremas, N.2
-
15
-
-
68849110176
-
From nature to drug discovery: The indole scaffold as a "privileged structure"
-
de Sa Alves, F.R.; Barreiro, E.J.; Fraga, C.A.M. From nature to drug discovery: the indole scaffold as a "privileged structure". Mini Rev. Med. Chem., 2009, 9, 782-793.
-
(2009)
Mini Rev. Med. Chem.
, vol.9
, pp. 782-793
-
-
De Sa Alves, F.R.1
Barreiro, E.J.2
Fraga, C.A.M.3
-
16
-
-
0024239320
-
Methods for drug discovery: Development of potent, selective, orally effective cholecystokinin antagonists
-
DOI 10.1021/jm00120a002
-
Evans, B.; Rittle, K.; Bock, M.; DiPardo, R.; Freidinger, R.; Whitter, W.; Lundell, G.; Veber, D.; Anderson, P. Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists. J. Med. Chem., 1988, 31, 2235-2246. (Pubitemid 19001640)
-
(1988)
Journal of Medicinal Chemistry
, vol.31
, Issue.12
, pp. 2235-2246
-
-
Evans, B.E.1
Rittle, K.E.2
Bock, M.G.3
DiPardo, R.M.4
Freidinger, R.M.5
Whitter, W.L.6
Lundell, G.F.7
Veber, D.F.8
Anderson, P.S.9
Chang, R.S.L.10
Lotti, V.J.11
Cerino, D.J.12
Chen, T.B.13
Kling, P.J.14
Kunkel, K.A.15
Springer, J.P.16
Hirshfield, J.17
-
17
-
-
0037011890
-
Development of a virtual screening method for identification of "frequent hitters" in compound libraries
-
DOI 10.1021/jm010934d
-
Roche, O.; Schneider, P.; Zuegge, J.; Guba, W.; Kansy, M.; Alanine, A.; Bleicher, K.; Danel, F.; Gutknecht, E.M.; Rogers-Evans, M.; Neidhart, W.; Stalder, H.; Dillon, M.; Sjogren, E.; Fotouhi, N.; Gillespie, P.; Goodnow, R.; Harris, W.; Jones, P.; Taniguchi, M.; Tsujii, S.; von der Saal, W.; Zimmermann, G.; Schneider, G.J. Development of a virtual screening method for identification of "frequent hitters" in compound libraries. J. Med. Chem., 2002, 45, 137-142. (Pubitemid 34038548)
-
(2002)
Journal of Medicinal Chemistry
, vol.45
, Issue.1
, pp. 137-142
-
-
Roche, O.1
Schneider, P.2
Zuegge, J.3
Guba, W.4
Kansy, M.5
Alanine, A.6
Bleicher, K.7
Danel, F.8
Gutknecht, E.-M.9
Rogers-Evans, M.10
Neidhart, W.11
Stalder, H.12
Dillon, M.13
Sjogren, E.14
Fotouhi, N.15
Gillespie, P.16
Goodnow, R.17
Harris, W.18
Jones, P.19
Taniguchi, M.20
Tsujii, S.21
Von Der Saal, W.22
Zimmermann, G.23
Schneider, G.24
more..
-
18
-
-
11144320699
-
Navigating chemical space for biology and medicine
-
DOI 10.1038/nature03193
-
Lipinski, C.; Hopkins, A. Navigating chemical space for biology and medicine. Nature, 2004, 432, 855-861. (Pubitemid 40037141)
-
(2004)
Nature
, vol.432
, Issue.7019
, pp. 855-861
-
-
Lipinski, C.1
Hopkins, A.2
-
19
-
-
11144341956
-
Chemical space and biology
-
DOI 10.1038/nature03192
-
Dobson, C.M. Chemical space and biology. Nature, 2004, 7019, 824-828. (Pubitemid 40037137)
-
(2004)
Nature
, vol.432
, Issue.7019
, pp. 824-828
-
-
Dobson, C.M.1
-
20
-
-
0030039619
-
The art and practice of structure-based drug design: A molecular modeling perspective
-
DOI 10.1002/(SICI)1098-1128(199601)16:1<3::AID-MED1>3.0.CO;2-6
-
Bohacek, R.S.; McMartin, C.; Guida, W.C. The art and practice of structurebased drug design: a molecular modeling perspective. Med. Res. Rev., 1996, 16, 3-50. (Pubitemid 26037075)
-
(1996)
Medicinal Research Reviews
, vol.16
, Issue.1
, pp. 3-50
-
-
Bohacek, R.S.1
McMartin, C.2
Guida, W.C.3
-
21
-
-
44949134801
-
The impact of natural products upon modern drug discovery
-
Ganesan, A. The impact of natural products upon modern drug discovery. Curr. Opin. Chem. Biol., 2008, 12, 306-317.
-
(2008)
Curr. Opin. Chem. Biol.
, vol.12
, pp. 306-317
-
-
Ganesan, A.1
-
22
-
-
0038042482
-
Chemical substructures in drug discovery
-
DOI 10.1016/S1359-6446(03)02740-5, PII S1359644603027405
-
Merlot, C.; Domine, D.; Cleva, C.; Church, D.J. Chemical substructures in drug discovery. Drug Discov. Today, 2003, 8, 594-602. (Pubitemid 36875723)
-
(2003)
Drug Discovery Today
, vol.8
, Issue.13
, pp. 594-602
-
-
Merlot, C.1
Domine, D.2
Cleva, C.3
Church, D.J.4
-
23
-
-
84870999598
-
Pyramid: An integrated platform for fragment-based drug discovery
-
Jahnke, W.; Erlanson, D.A., Eds.; Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim
-
Davies, T.G.; van Montfort, R.L.M.; Williams, G.; Jhoti, H. Pyramid: An Integrated Platform for Fragment-Based Drug Discovery. In: Fragment-Based Approaches in Drug Discovery; Jahnke, W.; Erlanson, D.A., Eds.; Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim, 2006; pp. 193-214.
-
(2006)
Fragment-Based Approaches in Drug Discovery
, pp. 193-214
-
-
Davies, T.G.1
Van Montfort, R.L.M.2
Williams, G.3
Jhoti, H.4
-
24
-
-
0032572819
-
Can we learn to distinguish between 'drug-like' and 'nondrug-like' molecules?
-
DOI 10.1021/jm970666c
-
Ajay, A.; Walters, W.P.; Murcko, M.A. Can we learn to distinguish between "drug-like" and "nondrug-like" molecules? J. Med. Chem., 1998, 41, 3314-3324. (Pubitemid 28406538)
-
(1998)
Journal of Medicinal Chemistry
, vol.41
, Issue.18
, pp. 3314-3324
-
-
Ajay, A.1
Walters, W.P.2
Murcko, M.A.3
-
25
-
-
0032572816
-
A scoring scheme for discriminating between drugs and nondrugs
-
DOI 10.1021/jm9706776
-
Sadowski, J.; Kubinyi, H. A scoring scheme for discriminating between drugs and nondrugs. J. Med. Chem., 1998, 41, 3325-3329. (Pubitemid 28406539)
-
(1998)
Journal of Medicinal Chemistry
, vol.41
, Issue.18
, pp. 3325-3329
-
-
Sadowski, J.1
Kubinyi, H.2
-
26
-
-
0035289779
-
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
-
DOI 10.1016/S0169-409X(00)00129-0, PII S0169409X00001290
-
Lipinski, C.A.; Lombardo, F.; Dominy, B.W.; Feeney, P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev., 2001, 46, 3-26. (Pubitemid 33653411)
-
(2000)
Advanced Drug Delivery Reviews
, vol.46
, Issue.1-3
, pp. 3-26
-
-
Lipinski, C.A.1
Lombardo, F.2
Dominy, B.W.3
Feeney, P.J.4
-
27
-
-
0037030653
-
Molecular properties that influence the oral bioavailability of drug candidates
-
DOI 10.1021/jm020017n
-
Veber, D.F.; Johnson, S.R.; Cheng, H.Y.; Smith, B.R.; Ward, K.W.; Kopple, K.D. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem., 2002, 45, 2615-2623. (Pubitemid 34595232)
-
(2002)
Journal of Medicinal Chemistry
, vol.45
, Issue.12
, pp. 2615-2623
-
-
Veber, D.F.1
Johnson, S.R.2
Cheng, H.-Y.3
Smith, B.R.4
Ward, K.W.5
Kopple, K.D.6
-
28
-
-
79960239942
-
Definition of drug-likeness for compound affinity
-
Fukunishi, Y.; Nakamura, H. Definition of drug-likeness for compound affinity. J. Chem. Inf. Model., 2011, 51, 1012-1016.
-
(2011)
J. Chem. Inf. Model.
, vol.51
, pp. 1012-1016
-
-
Fukunishi, Y.1
Nakamura, H.2
-
29
-
-
77956028583
-
Model-free drug-likeness from fragments
-
Ursu, O.; Oprea, T.I. Model-free drug-likeness from fragments. J. Chem. Inf. Model., 2010, 50, 1387-1394.
-
(2010)
J. Chem. Inf. Model.
, vol.50
, pp. 1387-1394
-
-
Ursu, O.1
Oprea, T.I.2
-
30
-
-
2942564021
-
Pursuing the leadlikeness concept in pharmaceutical research
-
DOI 10.1016/j.cbpa.2004.04.003, PII S1367593104000493
-
Hann, M.M.; Oprea, T.I. Pursuing the leadlikeness concept in pharmaceutical research. Curr. Opin. Chem. Biol., 2004, 8, 255-263. (Pubitemid 38759400)
-
(2004)
Current Opinion in Chemical Biology
, vol.8
, Issue.3
, pp. 255-263
-
-
Hann, M.M.1
Oprea, T.I.2
-
31
-
-
0141726877
-
"Rule of three" for fragmentbased lead discovery?
-
Congreve, M.; Carr, R.; Murray, C.; Jhoti, H. A "rule of three" for fragmentbased lead discovery? Drug Discov. Today, 2003, 8, 876-877.
-
(2003)
Drug Discov. Today
, vol.8
, pp. 876-877
-
-
Congreve, M.1
Carr, R.2
Murray, C.3
Jhoti, H.A.4
-
32
-
-
33751239466
-
In silico ADMET traffic lights as a tool for the prioritization of HTS hits
-
DOI 10.1002/cmdc.200600168
-
Lobell, M.; Hendrix, M.; Hinzen, B.; Keldenich, J.; Meier, H.; Schmeck, C.; Schohe-Loop, R.; Wunberg, T.; Hillisch, A. In silico ADMET traffic lights as a tool for the prioritization of HTS hits. ChemMedChem, 2006, 1, 1229-1236. (Pubitemid 44786929)
-
(2006)
ChemMedChem
, vol.1
, Issue.11
, pp. 1229-1236
-
-
Lobell, M.1
Hendrix, M.2
Hinzen, B.3
Keldenich, J.4
Meier, H.5
Schmeck, C.6
Schohe-Loop, R.7
Wunberg, T.8
Hillisch, A.9
-
33
-
-
46249123633
-
A maximum common substructure-based algorithm for searching and predicting drug-like compounds
-
DOI 10.1093/bioinformatics/btn186
-
Cao, Y.; Jiang, T.; Girke, T. A maximum common substructure-based algorithm for searching and predicting drug-like compounds. Bioinformatics, 2008, 24, i366-374. (Pubitemid 351911692)
-
(2008)
Bioinformatics
, vol.24
, Issue.13
-
-
Cao, Y.1
Jiang, T.2
Girke, T.3
-
34
-
-
41549115075
-
Assessing drug-likeness - What are we missing?
-
Vistoli, G.; Pedretti, A.; Testa, B. Assessing drug-likeness - what are we missing? Drug Discov. Today, 2008, 13, 285-294.
-
(2008)
Drug Discov. Today
, vol.13
, pp. 285-294
-
-
Vistoli, G.1
Pedretti, A.2
Testa, B.3
-
36
-
-
33845511093
-
Automatic and efficient decomposition of two-dimensional structures of small molecules for fragment-based high-throughput docking
-
DOI 10.1021/jm060838i
-
Kolb, P.; Caflisch, A. Automatic and efficient decomposition of twodimensional structures of small molecules for fragment-based highthroughput docking. J. Med. Chem., 2006, 49, 7384-7392. (Pubitemid 44913398)
-
(2006)
Journal of Medicinal Chemistry
, vol.49
, Issue.25
, pp. 7384-7392
-
-
Kolb, P.1
Caflisch, A.2
-
37
-
-
51849144627
-
Knowledge based prediction of ligand binding modes and rational inhibitor design for kinase drug discovery
-
Ghose, A.K.; Herbertz, T.; Pippin, D.A.; Salvino, J.M.; Mallamo, J.P. Knowledge based prediction of ligand binding modes and rational inhibitor design for kinase drug discovery. J. Med. Chem., 2008, 51, 5149-5171.
-
(2008)
J. Med. Chem.
, vol.51
, pp. 5149-5171
-
-
Ghose, A.K.1
Herbertz, T.2
Pippin, D.A.3
Salvino, J.M.4
Mallamo, J.P.5
-
38
-
-
3042689621
-
Fragment-based drug discovery
-
DOI 10.1021/jm040031v
-
Erlanson, D.A.; McDowell, R.S.; O'Brien, T. Fragment-based drug discovery. J. Med. Chem., 2004, 47, 3463-3482. (Pubitemid 38822007)
-
(2004)
Journal of Medicinal Chemistry
, vol.47
, Issue.14
, pp. 3463-3482
-
-
Erlanson, D.A.1
McDowell, R.S.2
O'Brien, T.3
-
39
-
-
78650633021
-
Computational medicinal chemistry in fragment-based drug discovery: What, how and when
-
Rabal, O.; Urbano-Cuadrado, M.; Oyarzabal, J. Computational medicinal chemistry in fragment-based drug discovery: what, how and when. Future Med. Chem., 2011, 3, 95-134.
-
(2011)
Future Med. Chem.
, vol.3
, pp. 95-134
-
-
Rabal, O.1
Urbano-Cuadrado, M.2
Oyarzabal, J.3
-
40
-
-
84860510658
-
Finding discriminative molecular fragments
-
Hamburg, Germany, September 15-18
-
Borgelt, C.; Hofer, H.; Berthold, M. Finding Discriminative Molecular Fragments. In: Workshop Information Mining -Navigating Large Heterogeneous Spaces of Multimedia Information, Proceedings of the 26th German Conference on Artificial Intelligence, Hamburg, Germany, September 15-18, 2003.
-
(2003)
Workshop Information Mining -Navigating Large Heterogeneous Spaces of Multimedia Information, Proceedings of the 26th German Conference on Artificial Intelligence
-
-
Borgelt, C.1
Hofer, H.2
Berthold, M.3
-
41
-
-
33646258711
-
Mining a chemical database for fragment co-occurrence: Discovery of "chemical clichés"
-
Lameijer, E.W.; Kok, J.N.; Back, T.; Ijzerman, A.P. Mining a chemical database for fragment co-occurrence: discovery of "chemical clichés". J. Chem. Inf. Model., 2006, 46, 553-562.
-
(2006)
J. Chem. Inf. Model.
, vol.46
, pp. 553-562
-
-
Lameijer, E.W.1
Kok, J.N.2
Back, T.3
Ijzerman, A.P.4
-
42
-
-
57549115967
-
Identification and selection of "privileged fragments" suitable for primary screening
-
Gianti, E.; Sartori, L. Identification and selection of "privileged fragments" suitable for primary screening. J. Chem. Inf. Model., 2008, 48, 2129-2139.
-
(2008)
J. Chem. Inf. Model.
, vol.48
, pp. 2129-2139
-
-
Gianti, E.1
Sartori, L.2
-
43
-
-
0032058905
-
RECAP - Retrosynthetic Combinatorial Analysis Procedure: A powerful new technique for identifying privileged molecular fragments with useful applications in combinatorial chemistry
-
Lewell, X.Q.; Judd, D.B.; Watson, S.P.; Hann, M.M. RECAP - retrosynthetic combinatorial analysis procedure: a powerful new technique for identifying privileged molecular fragments with useful applications in combinatorial chemistry. J. Chem. Inf. Comput. Sci., 1998, 38, 511-522. (Pubitemid 128594467)
-
(1998)
Journal of Chemical Information and Computer Sciences
, vol.38
, Issue.3
, pp. 511-522
-
-
Lewell, X.Q.1
Judd, D.B.2
Watson, S.P.3
Hann, M.M.4
-
44
-
-
70249139317
-
Receptor dependent multidimensional QSAR for modeling drugreceptor interactions
-
Polanski, J. Receptor dependent multidimensional QSAR for modeling drugreceptor interactions. Curr. Med. Chem., 2009, 16, 3243-3257.
-
(2009)
Curr. Med. Chem.
, vol.16
, pp. 3243-3257
-
-
Polanski, J.1
-
46
-
-
84859906267
-
Recent advances in development, validation and exploitation of QSAR models
-
John Wiley & Sons
-
Tropsha, A. Recent Advances in Development, Validation and Exploitation of QSAR Models. In: Burger's Medicinal Chemistry, Drug Discovery and Development; John Wiley & Sons, 2010; pp. 1-30.
-
(2010)
Burger's Medicinal Chemistry, Drug Discovery and Development
, pp. 1-30
-
-
Tropsha, A.1
-
47
-
-
0001376170
-
Potential drugs and nondrugs: Prediction and identification of important structural features
-
Wagener, M.; van Geerestein, V.J. Potential drugs and nondrugs: prediction and identification of important structural features. J. Chem. Inf. Comput. Sci., 2000, 40, 280-292.
-
(2000)
J. Chem. Inf. Comput. Sci.
, vol.40
, pp. 280-292
-
-
Wagener, M.1
Van Geerestein, V.J.2
-
48
-
-
78650699097
-
Molecular topology analysis of the differences between drugs, clinical candidate compounds, and bioactive molecules
-
Chen, H.; Yang, Y.; Engkvist, O. Molecular topology analysis of the differences between drugs, clinical candidate compounds, and bioactive molecules. J. Chem. Inf. Model., 2010, 50, 2141-2150.
-
(2010)
J. Chem. Inf. Model.
, vol.50
, pp. 2141-2150
-
-
Chen, H.1
Yang, Y.2
Engkvist, O.3
-
49
-
-
0034073605
-
Property distribution of drug-related chemical databases
-
DOI 10.1023/A:1008130001697
-
Oprea, T.I. Property distribution of drug-related chemical databases. J. Comput. Aided Mol. Des., 2000, 14, 251-264. (Pubitemid 30175944)
-
(2000)
Journal of Computer-Aided Molecular Design
, vol.14
, Issue.3
, pp. 251-264
-
-
Oprea, T.I.1
-
50
-
-
33751313329
-
Knowledge-based chemoinformatic approaches to drug discovery
-
DOI 10.1016/j.drudis.2006.10.012, PII S1359644606004338
-
Ghose, A.K.; Herbertz, T.; Salvino, J.M.; Mallamo, J.P. Knowledge-based chemoinformatic approaches to drug discovery. Drug Discov. Today, 2006, 11, 1107-1114. (Pubitemid 44803112)
-
(2006)
Drug Discovery Today
, vol.11
, Issue.23-24
, pp. 1107-1114
-
-
Ghose, A.K.1
Herbertz, T.2
Salvino, J.M.3
Mallamo, J.P.4
-
51
-
-
35748934487
-
The influence of drug-like concepts on decision-making in medicinal chemistry
-
DOI 10.1038/nrd2445, PII NRD2445
-
Leeson, P.D.; Springthorpe, B. The influence of drug-like concepts on decision-making in medicinal chemistry. Nat. Rev. Drug Discov., 2007, 6, 881-890. (Pubitemid 350042396)
-
(2007)
Nature Reviews Drug Discovery
, vol.6
, Issue.11
, pp. 881-890
-
-
Leeson, P.D.1
Springthorpe, B.2
-
52
-
-
33644872086
-
Privileged structures as leads in medicinal chemistry
-
Costantino, L.; Barlocco, D. Privileged structures as leads in medicinal chemistry. Curr. Med. Chem., 2006, 13, 65-85.
-
(2006)
Curr. Med. Chem.
, vol.13
, pp. 65-85
-
-
Costantino, L.1
Barlocco, D.2
-
53
-
-
60549099994
-
Detection and assignment of common scaffolds in project databases of lead molecules
-
Clark, A.M.; Labute, P. Detection and assignment of common scaffolds in project databases of lead molecules. J. Med. Chem., 2009, 52, 469-483.
-
(2009)
J. Med. Chem.
, vol.52
, pp. 469-483
-
-
Clark, A.M.1
Labute, P.2
-
54
-
-
70349425790
-
Recent progress in fragment-based lead discovery
-
Schulz, M.N.; Hubbard, R.E. Recent progress in fragment-based lead discovery. Curr. Opin. Pharmacol., 2009, 9, 615-621.
-
(2009)
Curr. Opin. Pharmacol.
, vol.9
, pp. 615-621
-
-
Schulz, M.N.1
Hubbard, R.E.2
-
55
-
-
36749018204
-
Privileged structures: A useful concept for the rational design of new lead drug candidates
-
DOI 10.2174/138955707782331722
-
Duarte, C.D.; Barreiro, E.J.; Fraga, C.A.M. Privileged structures: a useful concept for the rational design of new lead drug candidates. Mini Rev. Med. Chem., 2007, 7, 1108-1119. (Pubitemid 350200217)
-
(2007)
Mini-Reviews in Medicinal Chemistry
, vol.7
, Issue.11
, pp. 1108-1119
-
-
Duarte, C.D.1
Barreiro, E.J.2
Fraga, C.A.M.3
-
56
-
-
0036589285
-
Current trends in lead discovery: Are we looking for the appropriate properties?
-
DOI 10.1023/A:1020877402759
-
Oprea, T.I. Current trends in lead discovery: are we looking for the appropriate properties? J. Comput. Aided Mol. Des., 2002, 16, 325-334. (Pubitemid 35414666)
-
(2002)
Journal of Computer-Aided Molecular Design
, vol.16
, Issue.5-6
, pp. 325-334
-
-
Oprea, T.I.1
-
57
-
-
33947280523
-
Lead-like, drug-like or "Pub-like": How different are they?
-
DOI 10.1007/s10822-007-9105-3
-
Oprea, T.I.; Allu, T.K.; Fara, D.C.; Rad, R.F.; Ostopovici, L.; Bologa, C.G. Lead-like, drug-like or "Pub-like": how different are they? J. Comput. Aided Mol. Des., 2010, 21, 113-119. (Pubitemid 46416670)
-
(2007)
Journal of Computer-Aided Molecular Design
, vol.21
, Issue.1-3
, pp. 113-119
-
-
Oprea, T.I.1
Allu, T.K.2
Fara, D.C.3
Rad, R.F.4
Ostopovici, L.5
Bologa, C.G.6
-
58
-
-
1242271305
-
Molecular recognition: The fragment approach in lead generation
-
DOI 10.1016/S1359-6446(03)03007-1, PII S1359644603030071
-
Fattori, D. Molecular recognition: the fragment approach in lead generation. Drug Discov. Today, 2004, 9, 229-238. (Pubitemid 38230022)
-
(2004)
Drug Discovery Today
, vol.9
, Issue.5
, pp. 229-238
-
-
Fattori, D.1
-
59
-
-
2942702317
-
SVM-based feature selection for characterization of focused compound collections
-
Byvatov, E.; Schneider, G.J. SVM-based feature selection for characterization of focused compound collections. J. Chem. Inf. Comput. Sci., 2004, 44, 993-999.
-
(2004)
J. Chem. Inf. Comput. Sci.
, vol.44
, pp. 993-999
-
-
Byvatov, E.1
Schneider, G.J.2
-
60
-
-
19944391612
-
Target-related Affinity Profiling: Telik's lead discovery technology
-
DOI 10.2174/1568026053828394
-
Beroza, P.; Damodaran, K.; Lum, R.T. Target-related affinity profiling: Telik's lead discovery technology. Curr. Top. Med. Chem., 2005, 5, 371-381. (Pubitemid 40753874)
-
(2005)
Current Topics in Medicinal Chemistry
, vol.5
, Issue.4
, pp. 371-381
-
-
Beroza, P.1
Damodaran, K.2
Lum, R.T.3
-
62
-
-
0036214750
-
Virtual screening in drug discovery: Methods, expectations and reality
-
Bajorath, J. Virtual screening: methods, expectations and reality. Curr. Drug Discov., 2002, 2, 24-28. (Pubitemid 34269451)
-
(2002)
Current Drug Discovery
, Issue.MAR.
, pp. 24-28
-
-
Bajorath, J.1
-
63
-
-
0036835460
-
Integration of virtual and high-throughput screening
-
DOI 10.1038/nrd941
-
Bajorath, J. Integration of virtual and high-throughput screening. Nat. Rev. Drug Discov., 2002, 1, 882-894. (Pubitemid 37361583)
-
(2002)
Nature Reviews Drug Discovery
, vol.1
, Issue.11
, pp. 882-894
-
-
Bajorath, J.1
-
64
-
-
0036980746
-
Chemical similarity and biological activities
-
Kubinyi, H. Chemical similarity and biological activities. J. Braz. Chem. Soc., 2002, 13, 717-726. (Pubitemid 36181535)
-
(2002)
Journal of the Brazilian Chemical Society
, vol.13
, Issue.6
, pp. 717-726
-
-
Kubinyi, H.1
-
65
-
-
34249085274
-
How can structural similarity analysis help in category formation?
-
DOI 10.1080/10629360701306050, PII 778871248
-
Jaworska, J.; Nikolova-Jeliazkova, N. How can structural similarity analysis help in category formation? SAR QSAR Environ. Res., 2007, 18, 195-207. (Pubitemid 46789491)
-
(2007)
SAR and QSAR in Environmental Research
, vol.18
, Issue.3-4
, pp. 195-207
-
-
Jaworska, J.1
Nikolova-Jeliazkova, N.2
-
66
-
-
4243159924
-
Privileged structures: Applications in drug discovery
-
DeSimone, R.W.; Currie, K.S.; Mitchell, S.A.; Darrow, J.W.; Pippin, D.A. Privileged structures: applications in drug discovery. Comb. Chem. High Throughput Screen., 2004, 7, 473-494.
-
(2004)
Comb. Chem. High Throughput Screen.
, vol.7
, pp. 473-494
-
-
Desimone, R.W.1
Currie, K.S.2
Mitchell, S.A.3
Darrow, J.W.4
Pippin, D.A.5
-
68
-
-
33645422011
-
Are target-family-privileged substructures truly privileged?
-
Schnur, D.M.; Hermsmeier, M.A.; Tebben, A.J. Are target-family-privileged substructures truly privileged? J. Med. Chem., 2006, 49, 2000-2009.
-
(2006)
J. Med. Chem.
, vol.49
, pp. 2000-2009
-
-
Schnur, D.M.1
Hermsmeier, M.A.2
Tebben, A.J.3
-
69
-
-
65249109527
-
Molecular substructure mining approaches for computer-aided drug discovery: A review
-
Ioannina Greece October
-
Nicolaou, C.A.; Pattichis, C.S. Molecular Substructure Mining Approaches for Computer-Aided Drug Discovery: A Review. In: Proceedings of ITAB; Ioannina, Greece, October 26-28, 2006.
-
(2006)
Proceedings of ITAB
, pp. 26-28
-
-
Nicolaou, C.A.1
Pattichis, C.S.2
-
70
-
-
0842304428
-
Recognition of privileged structures by G-protein coupled receptors
-
DOI 10.1021/jm0309452
-
Bondensgaard, K.; Ankersen, M.; Thogersen, H.; Hansen, B.S.; Wulff, B.S.; Bywater, R.P. Recognition of privileged structures by G-protein coupled receptors. J. Med. Chem., 2004, 47, 888-899. (Pubitemid 38176791)
-
(2004)
Journal of Medicinal Chemistry
, vol.47
, Issue.4
, pp. 888-899
-
-
Bondensgaard, K.1
Ankersen, M.2
Thogersen, H.3
Hansen, B.S.4
Wulff, B.S.5
Bywater, R.P.6
-
71
-
-
0037366605
-
The combinatorial synthesis of bicyclic privileged structures or privileged substructures
-
Horton, D.A.; Bourne, G.T.; Smythe, M.L. The combinatorial synthesis of bicyclic privileged structures or privileged substructures. Chem. Rev., 2003, 103, 893-930.
-
(2003)
Chem. Rev.
, vol.103
, pp. 893-930
-
-
Horton, D.A.1
Bourne, G.T.2
Smythe, M.L.3
-
72
-
-
39049124587
-
Privileged scaffolds targeting reverse-turn and helix recognition
-
DOI 10.1517/14728222.12.1.101
-
Che, Y.; Marshall, G.R. Privileged scaffolds targeting reverse-turn and helix recognition. Expert Opin. Ther. Targets, 2008, 12, 101-114. (Pubitemid 351247166)
-
(2008)
Expert Opinion on Therapeutic Targets
, vol.12
, Issue.1
, pp. 101-114
-
-
Che, Y.1
Marshall, G.R.2
-
73
-
-
0037138701
-
Enantioselective organocatalytic indole alkylations. Design of a new and highly effective chiral amine for iminium catalysis
-
DOI 10.1021/ja017255c
-
Austin, J.F.; MacMillan, D.W.C. Enantioselective organocatalytic indole alkylations. Design of a new and highly effective chiral amine for iminium catalysis. J. Am. Chem. Soc., 2002, 124, 1172-1173. (Pubitemid 34169116)
-
(2002)
Journal of the American Chemical Society
, vol.124
, Issue.7
, pp. 1172-1173
-
-
Austin, J.F.1
MacMillan, D.W.C.2
-
74
-
-
0034618541
-
Privileged molecules for protein binding identified from NMR-based screening
-
Hajduk, P.J.; Bures, M.; Praestgaard, J.; Fesik, S.W. Privileged molecules for protein binding identified from NMR-based screening. J. Med. Chem., 2000, 43, 3443-3447.
-
(2000)
J. Med. Chem.
, vol.43
, pp. 3443-3447
-
-
Hajduk, P.J.1
Bures, M.2
Praestgaard, J.3
Fesik, S.W.4
-
75
-
-
0032474520
-
Synthesis and biological activities of phenyl piperazine- based peptidomimetic growth hormone secretagogues
-
DOI 10.1016/S0960-894X(98)00238-8, PII S0960894X98002388
-
Barakat, K.J.; Cheng, K.; Chan, W.W.; Butler, B.S.; Jacks, T.M.; Schleim, K.D.; Hora, D.F.; Hickey, G.J.; Smith, R.G.; Patchett, A.A.; Nargund, R.P. Synthesis and biological activities of phenyl piperazine-based peptidomimetic growth hormone secretagogues. Bioorg. Med. Chem. Lett., 1998, 8, 1431-1436. (Pubitemid 28261315)
-
(1998)
Bioorganic and Medicinal Chemistry Letters
, vol.8
, Issue.11
, pp. 1431-1436
-
-
Barakat, K.J.1
Cheng, K.2
Chan, W.W.-S.3
Butler, B.S.4
Jacks, T.M.5
Schleim, K.D.6
Hora Jr., D.F.7
Hickey, G.J.8
Smith, R.G.9
Patchett, A.A.10
Nargund, R.P.11
-
76
-
-
0034601292
-
2 receptors
-
DOI 10.1016/S0165-1838(00)00128-4, PII S0165183800001284
-
Jacobson, K.A.; Kim, Y.C.; King, B.F. In search of selective P2 receptor ligands: interaction of dihydropyridine derivatives at recombinant rat P2X(2) receptors. J. Auton. Nerv. Syst., 2000, 81, 152-157. (Pubitemid 30408492)
-
(2000)
Journal of the Autonomic Nervous System
, vol.81
, Issue.1-3
, pp. 152-157
-
-
Jacobson, K.A.1
Kim, Y.-C.2
King, B.F.3
-
77
-
-
0035874704
-
2,6-Dichloro-9-thiabicyclo[3.3.1]nonane: A privileged, bivalent scaffold for the display of nucleophilic components
-
DOI 10.1021/jo015632y
-
Converso, A.; Burow, K.; Marzinzik, A.; Sharpless, K.B.; Finn, M.G. 2,6-Dichloro-9-thiabicyclo[3.3.1]nonane: a privileged bivalent scaffold for the display of nucleophilic components. J. Org. Chem., 2001, 66, 4386-4392. (Pubitemid 32867583)
-
(2001)
Journal of Organic Chemistry
, vol.66
, Issue.12
, pp. 4386-4392
-
-
Converso, A.1
Burow, K.2
Marzinzik, A.3
Sharpless, K.B.4
Finn, M.G.5
-
78
-
-
0034684250
-
Natural product-like combinatorial libraries based on privileged structures. 1. General principles and solid-phase synthesis of benzopyrans
-
Nicolaou, K.C.; Pfefferkorn, J.A.; Roecker, A.J.; Cao, G.Q.; Barluenga, S.; Mitchell, H.J. Natural product-like combinatorial libraries based on privileged structures. 1. General principles and solid-phase synthesis of benzopyrans. J. Am. Chem. Soc., 2000, 122, 9939-9953.
-
(2000)
J. Am. Chem. Soc.
, vol.122
, pp. 9939-9953
-
-
Nicolaou, K.C.1
Pfefferkorn, J.A.2
Roecker, A.J.3
Cao, G.Q.4
Barluenga, S.5
Mitchell, H.J.6
-
79
-
-
0035382954
-
Discovery of novel antibacterial agents active against methicillin-resistant Staphylococcus aureus from combinatorial benzopyran libraries
-
Nicolaou, K.C.; Roecker, A.J.; Barluenga, S.; Pfefferkorn, J.A.; Cao, G.Q. Discovery of novel antibacterial agents active against methicillin- resistant Staphylococcus aureus from combinatorial benzopyran libraries. Chembiochem, 2001, 2, 460-465. (Pubitemid 33723578)
-
(2001)
ChemBioChem
, vol.2
, Issue.6
, pp. 460-465
-
-
Nicolaou, K.C.1
Roecker, A.J.2
Barluenga, S.3
Pfefferkorn, J.A.4
Cao, G.-Q.5
-
80
-
-
80053601542
-
Are pyridazines privileged structures?
-
Wermuth, C.G. Are pyridazines privileged structures? Medchemcomm, 2011, 2, 935-941.
-
(2011)
Medchemcomm
, vol.2
, pp. 935-941
-
-
Wermuth, C.G.1
-
81
-
-
77953505300
-
Quinoline-based antifungals
-
Musiol, R.; Serda, M.; Hensel-Bielowka, S.; Polanski, J. Quinoline-based antifungals. Curr. Med. Chem., 2010, 17, 1960-1973.
-
(2010)
Curr. Med. Chem.
, vol.17
, pp. 1960-1973
-
-
Musiol, R.1
Serda, M.2
Hensel-Bielowka, S.3
Polanski, J.4
-
82
-
-
79955004745
-
Quinoline as a privileged scaffold in cancer drug discovery
-
Solomon, V.R.; Lee, H. Quinoline as a privileged scaffold in cancer drug discovery. Curr. Med. Chem., 2011, 18, 1488-1508.
-
(2011)
Curr. Med. Chem.
, vol.18
, pp. 1488-1508
-
-
Solomon, V.R.1
Lee, H.2
-
83
-
-
0028151607
-
Nilvadipine: Profile of a new calcium antagonist. An overview
-
Rosenthal, J. Nilvadipine: profile of a new calcium antagonist. An overview. J. Cardiovasc. Pharmacol., 1994, 24 Suppl 2, S92-107. (Pubitemid 24369890)
-
(1994)
Journal of Cardiovascular Pharmacology
, vol.24
, Issue.SUPPL. 2
-
-
Rosenthal, J.1
-
84
-
-
84862904241
-
Intravenous Diazepam Midazolam and Lorazepam in acute seizure control
-
Epub ahead of print
-
Gathwala, G.; Goel, M.; Singh, J.; Mittal, K. Intravenous Diazepam, Midazolam and Lorazepam in acute seizure control. Indian J. Pediatr., 2011, Epub ahead of print.
-
(2011)
Indian J. Pediatr.
-
-
Gathwala, G.1
Goel, M.2
Singh, J.3
Mittal, K.4
-
85
-
-
0031690854
-
Anticonvulsant properties of 1,4-benzodiazepine derivatives in amygdaloid-kindled seizures and their chemical structure-related anticonvulsant action
-
DOI 10.1159/000028247
-
Fukinaga, M.; Ishizawa, K.; Kamei, C. Anticonvulsant properties of 1,4-benzodiazepine derivatives in amygdaloid-kindled seizures and their chemical structure-related anticonvulsant action. Pharmacology, 1998, 57, 233-241. (Pubitemid 28444865)
-
(1998)
Pharmacology
, vol.57
, Issue.5
, pp. 233-241
-
-
Fukinaga, M.1
Ishizawa, K.2
Kamei, C.3
-
86
-
-
0038179789
-
Cyclizine
-
Dodd, T.; Doyle, T. Cyclizine. Emerg. Med. J., 2003, 20, 302. (Pubitemid 36617341)
-
(2003)
Emergency Medicine Journal
, vol.20
, Issue.3
, pp. 302
-
-
Dodd, T.1
Doyle, T.2
-
87
-
-
79957574695
-
Buclizine is back again! This time as a pediatric appetite stimulant
-
Babu, T.A. Buclizine is back again! This time as a pediatric appetite stimulant. Indian J. Pharmacol., 2011, 43, 219.
-
(2011)
Indian J. Pharmacol.
, vol.43
, pp. 219
-
-
Babu, T.A.1
-
88
-
-
79952201907
-
Hydroxyzine for generalised anxiety disorder
-
Guaiana, G.; Barbui, C.; Cipriani, A. Hydroxyzine for generalised anxiety disorder. Cochrane Database Syst. Rev., 2010, 8, CD006815.
-
(2010)
Cochrane Database Syst. Rev.
, vol.8
-
-
Guaiana, G.1
Barbui, C.2
Cipriani, A.3
-
89
-
-
80054917722
-
Efficacy of second-generation antihistamines in patients with allergic rhinitis and comorbid asthma
-
Bachert, C.; Maspero, J. Efficacy of second-generation antihistamines in patients with allergic rhinitis and comorbid asthma. J. Asthma, 2011, 48, 965-973.
-
(2011)
J. Asthma
, vol.48
, pp. 965-973
-
-
Bachert, C.1
Maspero, J.2
-
90
-
-
39049173610
-
Nifedipine: A novel vasodilator
-
Taira, N. Nifedipine: a novel vasodilator. Drugs, 2006, 66, 1-3.
-
(2006)
Drugs
, vol.66
, pp. 1-3
-
-
Taira, N.1
-
91
-
-
39049097320
-
Antihypertensive effects of nifedipine and changing for modified-release formula
-
Kuwajima, I. Antihypertensive effects of nifedipine and changing for modified-release formula. Drugs, 2006, 66, 7-9.
-
(2006)
Drugs
, vol.66
, pp. 7-9
-
-
Kuwajima, I.1
-
92
-
-
84860542224
-
A systematic review of nicardipine vs labetalol for the management of hypertensive crises
-
Epub ahead of print
-
Peacock, W.F.; Hilleman, D.E.; Levy, P.D.; Rhoney, D.H.; Varon, J. A systematic review of nicardipine vs labetalol for the management of hypertensive crises. Am. J. Emerg. Med., 2011, Epub ahead of print.
-
(2011)
Am. J. Emerg. Med.
-
-
Peacock, W.F.1
Hilleman, D.E.2
Levy, P.D.3
Rhoney, D.H.4
Varon, J.5
-
93
-
-
37549010689
-
Effect of nilvadipine on regional cerebral blood flow in a patient with early Alzheimer disease
-
Matsuda, H.; Araki, N.; Kuji, I.; Ohkubo, T.; Imabayashi, E.; Shimazu, K. Effect of nilvadipine on regional cerebral blood flow in a patient with early Alzheimer disease. Clin. Nucl. Med., 2008, 33, 34-35.
-
(2008)
Clin. Nucl. Med.
, vol.33
, pp. 34-35
-
-
Matsuda, H.1
Araki, N.2
Kuji, I.3
Ohkubo, T.4
Imabayashi, E.5
Shimazu, K.6
-
94
-
-
0028791005
-
The evolving role of calcium channel blockers in the treatment of angina pectoris: Focus on felodipine
-
Gradman, A.H. The evolving role of calcium channel blockers in the treatment of angina pectoris: focus on felodipine. Can. J. Cardiol., 1995, 11 Suppl B, 14B-21B.
-
(1995)
Can. J. Cardiol.
, vol.11 SUPPL. B
-
-
Gradman, A.H.1
-
95
-
-
80555125035
-
Application of AT1-angiotensin II receptor blocker valsartan in clinical practice
-
Maksimov, M.L.; Mochkin, I.A.; Starodubtsev, A.K. Application of AT1-angiotensin II receptor blocker valsartan in clinical practice. Kardiologiia, 2011, 51, 77-84.
-
(2011)
Kardiologiia
, vol.51
, pp. 77-84
-
-
Maksimov, M.L.1
Mochkin, I.A.2
Starodubtsev, A.K.3
-
96
-
-
79952774764
-
Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138,769 individuals
-
Collaboration, T.A.T. Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138,769 individuals. J. Hypertens., 2011, 29, 623-635.
-
(2011)
J. Hypertens.
, vol.29
, pp. 623-635
-
-
Collaboration, T.A.T.1
-
97
-
-
65549122690
-
Esomeprazole: A proton pump inhibitor
-
Vachhani, R.; Olds, G.; Velanovich, V. Esomeprazole: a proton pump inhibitor. Expert Rev. Gastroenterol. Hepatol., 2009, 3, 15-27.
-
(2009)
Expert Rev. Gastroenterol. Hepatol.
, vol.3
, pp. 15-27
-
-
Vachhani, R.1
Olds, G.2
Velanovich, V.3
-
98
-
-
84855466015
-
Droperidol for treatment of nausea and vomiting in palliative care patients
-
Dorman, S.; Perkins, P. Droperidol for treatment of nausea and vomiting in palliative care patients. Cochrane Database Syst. Rev., 2010, 6, CD006938.
-
(2010)
Cochrane Database Syst. Rev.
, vol.6
-
-
Dorman, S.1
Perkins, P.2
-
99
-
-
63449120111
-
Mebendazole in parasitic infections other than those caused by soil-transmitted helminths
-
Canete, R.; Escobedo, A.A.; Almirall, P.; Gonzalez, M.E.; Brito, K.; Cimerman, S. Mebendazole in parasitic infections other than those caused by soil-transmitted helminths. Trans. R. Soc. Trop. Med. Hyg., 2009, 103, 437-442.
-
(2009)
Trans. R. Soc. Trop. Med. Hyg.
, vol.103
, pp. 437-442
-
-
Canete, R.1
Escobedo, A.A.2
Almirall, P.3
Gonzalez, M.E.4
Brito, K.5
Cimerman, S.6
-
100
-
-
68149181539
-
Emedastine difumarate: A review of its potential ameliorating effect for tissue remodeling in allergic diseases
-
Murota, H.; Katayama, I. Emedastine difumarate: a review of its potential ameliorating effect for tissue remodeling in allergic diseases. Expert Opin. Pharmacother., 2009, 10, 1859-1867.
-
(2009)
Expert Opin. Pharmacother.
, vol.10
, pp. 1859-1867
-
-
Murota, H.1
Katayama, I.2
-
101
-
-
0035987755
-
Review of zolmitriptan and its clinical applications in migraine
-
DOI 10.1517/14656566.3.7.993
-
Dowson, A.J.; Charlesworth, B. Review of zolmitriptan and its clinical applications in migraine. Expert Opin. Pharmacother., 2002, 3, 993-1005. (Pubitemid 34752516)
-
(2002)
Expert Opinion on Pharmacotherapy
, vol.3
, Issue.7
, pp. 993-1005
-
-
Dowson, A.J.1
Charlesworth, B.2
-
102
-
-
0031043628
-
Tissue selective inhibition of prostaglandin biosynthesis by etodolac
-
Dvornik, D.M. Tissue selective inhibition of prostaglandin biosynthesis by etodolac. J. Rheumatol. Suppl., 1997, 47, 40-47.
-
(1997)
J. Rheumatol. Suppl.
, vol.47
, pp. 40-47
-
-
Dvornik, D.M.1
-
103
-
-
80052664727
-
Effect of ergot alkaloids on contractility of bovine right ruminal artery and vein
-
Foote, A.P.; Harmon, D.L.; Strickland, J.R.; Bush, L.P.; Klotz, J.L. Effect of ergot alkaloids on contractility of bovine right ruminal artery and vein. J. Anim. Sci., 2011, 89, 2944-2949.
-
(2011)
J. Anim. Sci.
, vol.89
, pp. 2944-2949
-
-
Foote, A.P.1
Harmon, D.L.2
Strickland, J.R.3
Bush, L.P.4
Klotz, J.L.5
-
104
-
-
79952217204
-
The concept of privileged structures in rational drug design: Focus on acridine and quinoline scaffolds in neurodegenerative and protozoan diseases
-
Bongarzone, S.; Bolognesi, M.L. The concept of privileged structures in rational drug design: focus on acridine and quinoline scaffolds in neurodegenerative and protozoan diseases. Expert Opin. Drug Discov., 2011, 6, 251-268.
-
(2011)
Expert Opin. Drug Discov.
, vol.6
, pp. 251-268
-
-
Bongarzone, S.1
Bolognesi, M.L.2
-
105
-
-
0141792701
-
A specific mechanism of nonspecific inhibition
-
DOI 10.1021/jm030266r
-
McGovern, S.L.; Helfand, B.T.; Feng, B.; Shoichet, B.K. A specific mechanism of nonspecific inhibition. J. Med. Chem., 2003, 46, 4265-4272. (Pubitemid 37153008)
-
(2003)
Journal of Medicinal Chemistry
, vol.46
, Issue.20
, pp. 4265-4272
-
-
McGovern, S.L.1
Helfand, B.T.2
Feng, B.3
Shoichet, B.K.4
-
106
-
-
47349102980
-
Synthesis and pharmacological investigation of novel 2-aminothiazole- privileged aporphines
-
Liu, Z.; Chen, X.; Yu, L.; Zhen, X.; Zhang, A. Synthesis and pharmacological investigation of novel 2-aminothiazole-privileged aporphines. Bioorg. Med. Chem., 2008, 16, 6675-6681.
-
(2008)
Bioorg. Med. Chem.
, vol.16
, pp. 6675-6681
-
-
Liu, Z.1
Chen, X.2
Yu, L.3
Zhen, X.4
Zhang, A.5
-
107
-
-
77952477596
-
Privileged scaffolds for library design and drug discovery
-
Welsch, M.E.; Snyder, S.A; Stockwell, B.R. Privileged scaffolds for library design and drug discovery. Curr. Opin. Chem. Biol., 2010, 14, 347-361.
-
(2010)
Curr. Opin. Chem. Biol.
, vol.14
, pp. 347-361
-
-
Welsch, M.E.1
Snyder, S.A.2
Stockwell, B.R.3
-
108
-
-
18244382828
-
Combinatorial synthesis of 3-(Amidoalkyl) and 3-(Aminoalkyl)-2-arylindole derivatives: Discovery of potent ligands for a variety of G-protein coupled receptors
-
DOI 10.1016/S0960-894X(01)00665-5, PII S0960894X01006655
-
Willoughby, C.A; Hutchins, S.M.; Rosauer, K.G.; Dhar, M.J.; Chapman, K.T.; Chicchi, G.G.; Sadowski, S.; Weinberg, D.H.; Patel, S.; Malkowitz, L.; Di Salvo, J.; Pacholok, S.G.; Cheng, K. Combinatorial synthesis of 3-(amidoalkyl) and 3-(aminoalkyl)-2-arylindole derivatives: discovery of potent ligands for a variety of G-protein coupled receptors. Bioorg. Med. Chem. Lett., 2002, 12, 93-96. (Pubitemid 34008577)
-
(2002)
Bioorganic and Medicinal Chemistry Letters
, vol.12
, Issue.1
, pp. 93-96
-
-
Willoughby, C.A.1
Hutchins, S.M.2
Rosauer, K.G.3
Dhar, M.J.4
Chapman, K.T.5
Chicchi, G.G.6
Sadowski, S.7
Weinberg, D.H.8
Patel, S.9
Malkowitz, L.10
Di Salvo, J.11
Pacholok, S.G.12
Cheng, K.13
-
109
-
-
0033150476
-
Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors
-
DOI 10.1016/S1074-5521(99)80048-9
-
Chang, Y.T.; Gray, N.S.; Rosania, G.R.; Sutherlin, D.P.; Kwon, S.; Norman, T.C.; Sarohia, R.; Leost, M.; Meijer, L.; Schultz, P.G. Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors. Chem. Biol., 1999, 6, 361-375. (Pubitemid 29363169)
-
(1999)
Chemistry and Biology
, vol.6
, Issue.6
, pp. 361-375
-
-
Young-Tae, C.1
Gray, N.S.2
Rosania, G.R.3
Sutherlin, D.P.4
Kwon, S.5
Norman, T.C.6
Sarohia, R.7
Leost, M.8
Meijer, L.9
Schultz, P.G.10
-
110
-
-
67651099103
-
Combinatorial library synthesis and biological evaluation of pyrazolo[4,3-e][1,4]diazepine as a potential privileged structure
-
Lee, J.Y.; Kim, Y.C. Combinatorial library synthesis and biological evaluation of pyrazolo[4,3-e][1,4]diazepine as a potential privileged structure. ChemMedChem, 2009, 4, 733-737.
-
(2009)
ChemMedChem
, vol.4
, pp. 733-737
-
-
Lee, J.Y.1
Kim, Y.C.2
-
111
-
-
33845736461
-
Drugs in other drugs: A new look at drugs as fragments
-
DOI 10.1016/j.drudis.2006.11.011, PII S1359644606004727
-
Siegel, M.G.; Vieth, M. Drugs in other drugs: a new look at drugs as fragments. Drug Discov. Today, 2007, 12, 71-79. (Pubitemid 46014488)
-
(2007)
Drug Discovery Today
, vol.12
, Issue.1-2
, pp. 71-79
-
-
Siegel, M.G.1
Vieth, M.2
-
112
-
-
0037374498
-
The price of innovation: New estimates of drug development costs
-
DOI 10.1016/S0167-6296(02)00126-1
-
DiMasi, J.A.; Hansen, R.W.; Grabowski, H.G. The price of innovation: new estimates of drug developments costs. J. Health Econ., 2003, 22, 151-185. (Pubitemid 36279392)
-
(2003)
Journal of Health Economics
, vol.22
, Issue.2
, pp. 151-185
-
-
DiMasi, J.A.1
Hansen, R.W.2
Grabowski, H.G.3
-
113
-
-
13344284559
-
Scaffold hopping
-
DOI 10.1016/j.ddtec.2004.10.009, PII S1740674904000460
-
Bohm, H.; Flohr, A.; Stahl, M. Scaffold hopping. Drug Discov. Today Technol., 2004, 1, 217-224. (Pubitemid 40197570)
-
(2004)
Drug Discovery Today: Technologies
, vol.1
, Issue.3
, pp. 217-224
-
-
Bohm, H.-J.1
Flohr, A.2
Stahl, M.3
-
114
-
-
0031473381
-
Are me-too drugs justified?
-
Garattini, S. Are me-too drugs justified? J. Nephrol., 1997, 10, 283-294. (Pubitemid 28010023)
-
(1997)
Journal of Nephrology
, vol.10
, Issue.6
, pp. 283-294
-
-
Garattini, S.1
-
115
-
-
33847381100
-
A decade of fragment-based drug design: Strategic advances and lessons learned
-
DOI 10.1038/nrd2220, PII NRD2220
-
Hajduk, P.J.; Greer, J. A decade of fragment-based drug design: strategic advances and lessons learned. Nat. Rev. Drug Discov., 2007, 6, 211-219. (Pubitemid 46344625)
-
(2007)
Nature Reviews Drug Discovery
, vol.6
, Issue.3
, pp. 211-219
-
-
Hajduk, P.J.1
Greer, J.2
-
116
-
-
80051798254
-
Fragment-based lead discovery: Challenges and opportunities
-
Sun, C.; Petros, A.M.; Hajduk, P.J. Fragment-based lead discovery: challenges and opportunities. J. Comput. Aided Mol. Des., 2011, 25, 607-610.
-
(2011)
J. Comput. Aided Mol. Des.
, vol.25
, pp. 607-610
-
-
Sun, C.1
Petros, A.M.2
Hajduk, P.J.3
-
118
-
-
0035324944
-
Molecular complexity and its impact on the probability of finding leads for drug discovery
-
Hann, M.M.; Leach, A.R.; Harper, G. Molecular complexity and its impact on the probability of finding leads for drug discovery. J. Chem. Inf. Comput. Sci., 2001, 41, 856-864.
-
(2001)
J. Chem. Inf. Comput. Sci.
, vol.41
, pp. 856-864
-
-
Hann, M.M.1
Leach, A.R.2
Harper, G.3
-
121
-
-
85073148043
-
Virtual screening and molecular design based on hierarchical QSAR technology
-
Puzyn, T.; Leszczynski, J.; Cronin M., Eds.; Springer
-
Kuz'min, V.E.; Artemenko, A.G.; Muratov, E.N.; Polischuk, P.G.; Ognichenko, L.N.; Liahovsky, A.V.; Hromov, A.I. Virtual Screening and Molecular Design Based on Hierarchical QSAR Technology. In: Recent Advances in QSAR Studies: Methods and Applications; Puzyn, T.; Leszczynski, J.; Cronin, M., Eds.; Springer, 2010; pp. 127-176.
-
(2010)
Recent Advances in QSAR Studies: Methods and Applications
, pp. 127-176
-
-
Kuz'min, V.E.1
Artemenko, A.G.2
Muratov, E.N.3
Polischuk, P.G.4
Ognichenko, L.N.5
Liahovsky, A.V.6
Hromov, A.I.7
-
122
-
-
0001611960
-
Neural nets for the simulation of molecular recognition within MS-windows environment
-
Polanski, J. Neural nets for the simulation of molecular recognition within MS-Windows environment. J. Chem. Inf. Comput. Sci., 1996, 36, 694-705. (Pubitemid 126581719)
-
(1996)
Journal of Chemical Information and Computer Sciences
, vol.36
, Issue.4
, pp. 694-705
-
-
Polanski, J.1
-
123
-
-
0031138166
-
The receptor-like neural network for modeling corticosteroid and testosterone binding globulins
-
Polanski, J. The receptor-like neural network for modeling corticosteroid and testosterone binding globulins. J. Chem. Inf. Comput. Sci., 1997, 37, 553-561. (Pubitemid 127603565)
-
(1997)
Journal of Chemical Information and Computer Sciences
, vol.37
, Issue.3
, pp. 553-561
-
-
Polanski, J.1
-
124
-
-
0021529312
-
Artificial intelligence approach to structure-activity studies. Computer automated structure evaluation of biological activity of organic molecules
-
DOI 10.1021/ja00336a004
-
Klopman, G. Artificial intelligence approach to structure-activity studies. Computer automated structure evaluation of biological activity of organic molecules. J. Am. Chem. Soc., 1984, 106, 7315-7321. (Pubitemid 15216948)
-
(1984)
Journal of the American Chemical Society
, vol.106
, Issue.24
, pp. 7315-7321
-
-
Klopman, G.1
-
125
-
-
0022644866
-
Quantitative structure-activity relationships of beta-adrenergic agents. Application of the computer automated structure evaluation (CASE) technique of molecular fragment recognition
-
DOI 10.1016/S0022-5193(86)80134-5
-
Klopman, G.; Kalos, A.N. Quantitative structure-activity relationships of beta-adrenergic agents. Application of the computer automated structure evaluation (CASE) technique of molecular fragment recognition. J. Theor. Biol., 1986, 118, 199-214. (Pubitemid 16190411)
-
(1986)
Journal of Theoretical Biology
, vol.118
, Issue.2
, pp. 199-214
-
-
Klopman, G.1
Kalos, A.N.2
-
126
-
-
84860530251
-
Computer automated structure evaluation (CASE) of flavonoids as larval growth inhibitors
-
Klopman, G.; Venegas, R.E. Computer automated structure evaluation (CASE) of flavonoids as larval growth inhibitors. Pure Appl. Chem., 1988, 60, 265-270.
-
(1988)
Pure Appl. Chem.
, vol.60
, pp. 265-270
-
-
Klopman, G.1
Venegas, R.E.2
-
127
-
-
42949088496
-
Chemical fragments as foundations for understanding target space and activity prediction
-
DOI 10.1021/jm701399f
-
Sutherland, J.J.; Higgs, R.E.; Watson, I.; Vieth, M. Chemical fragments as foundations for understanding target space and activity prediction. J. Med. Chem., 2008, 51, 2689-2700. (Pubitemid 351620791)
-
(2008)
Journal of Medicinal Chemistry
, vol.51
, Issue.9
, pp. 2689-2700
-
-
Sutherland, J.J.1
Higgs, R.E.2
Watson, I.3
Vieth, M.4
-
128
-
-
65249092242
-
Computational approaches to fragment and substructure discovery and evaluation
-
1st ed.; Zartler, E.R.; Shapiro, M.J., Eds.; John Wiley & Sons
-
van der Horst, E.; Ijzerman, A.P. Computational Approaches to Fragment and Substructure Discovery and Evaluation. In: Fragment-Based Drug Discovery: a Practical Approach, 1st ed.; Zartler, E.R.; Shapiro, M.J., Eds.; John Wiley & Sons, 2008; pp. 199-222.
-
(2008)
Fragment-Based Drug Discovery: A Practical Approach
, pp. 199-222
-
-
Van Der Horst, E.1
Ijzerman, A.P.2
-
129
-
-
0012281570
-
HQSAR - A highly predictive QSAR technique based on molecular holograms
-
San Francisco, the USA, April 13-17
-
Hurst, T.; Heritage, T. HQSAR - a highly predictive QSAR technique based on molecular holograms. In: Book of Abstracts, 213th ACS National Meeting, San Francisco, the USA, April 13-17, 1997.
-
(1997)
Book of Abstracts, 213th ACS National Meeting
-
-
Hurst, T.1
Heritage, T.2
-
130
-
-
0037013438
-
CoMFA and HQSAR of acylhydrazide cruzain inhibitors
-
DOI 10.1016/S0960-894X(02)00189-0, PII S0960894X02001890
-
Rodrigues, C.R.; Flaherty, T.M.; Springer, C.; McKerrow, J.H.; Cohen, F.E. CoMFA and HQSAR of acylhydrazide cruzain inhibitors. Bioorg. Med. Chem. Lett., 2002, 12, 1537-1541. (Pubitemid 34521930)
-
(2002)
Bioorganic and Medicinal Chemistry Letters
, vol.12
, Issue.11
, pp. 1537-1541
-
-
Rodrigues, C.R.1
Flaherty, T.M.2
Springer, C.3
McKerrow, J.H.4
Cohen, F.E.5
-
131
-
-
1842639121
-
A comparative QSAR study using CoMFA, HQSAR, and FRED/SKEYS paradigms for estrogen receptor binding affinities of structurally diverse compounds
-
Waller, C.L. A comparative QSAR study using CoMFA, HQSAR, and FRED/SKEYS paradigms for estrogen receptor binding affinities of structurally diverse compounds. J. Chem. Inf. Comput. Sci., 1999, 44, 758-765.
-
(1999)
J. Chem. Inf. Comput. Sci.
, vol.44
, pp. 758-765
-
-
Waller, C.L.1
-
132
-
-
17844369895
-
Generalized fragment-substructure based property prediction method
-
DOI 10.1021/ci049744c
-
Clark, M. Generalized fragment-substructure based property prediction method. J. Chem. Inf. Model., 2005, 45, 30-38. (Pubitemid 40736953)
-
(2005)
Journal of Chemical Information and Modeling
, vol.45
, Issue.1
, pp. 30-38
-
-
Clark, M.1
-
133
-
-
0034869394
-
Computational approaches towards the rational design of drug-like compound libraries
-
Matter, H.; Baringhaus, K.H.; Naumann, T.; Klabunde, T.; Pirard, B. Computational approaches towards the rational design of drug-like compound libraries. Comb. Chem. High Throughput Screen., 2001, 4, 453-475. (Pubitemid 32808063)
-
(2001)
Combinatorial Chemistry and High Throughput Screening
, vol.4
, Issue.6
, pp. 453-475
-
-
Matter, H.1
Baringhaus, K.-H.2
Naumann, T.3
Klabunde, T.4
Pirard, B.5
-
134
-
-
0035438391
-
Is there a difference between leads and drugs? A historical perspective
-
Oprea, T.I.; Davis, A.M.; Teague, S.J.; Leeson, P.D. Is there a difference between leads and drugs? A historical perspective. J. Chem. Inf. Comput. Sci., 2001, 41, 1308-1315.
-
(2001)
J. Chem. Inf. Comput. Sci.
, vol.41
, pp. 1308-1315
-
-
Oprea, T.I.1
Davis, A.M.2
Teague, S.J.3
Leeson, P.D.4
-
135
-
-
4444262413
-
A minimalist approach to fragment-based ligand design using common rings and linkers: Application to kinase inhibitors
-
DOI 10.1002/prot.20173
-
Aronov, A.M.; Bemis, G.W. A minimalist approach to fragment-based ligand design using common rings and linkers: application to kinase inhibitors. Proteins, 2004, 57, 36-50. (Pubitemid 39195883)
-
(2004)
Proteins: Structure, Function and Genetics
, vol.57
, Issue.1
, pp. 36-50
-
-
Aronov, A.M.1
Bemis, G.W.2
-
136
-
-
41649105837
-
Kinase-likeness and kinase-privileged fragments: Toward virtual polypharmacology
-
DOI 10.1021/jm701021b
-
Aronov, A.M.; McClain, B.; Moody, C.S.; Murcko, M.A. Kinase-likeness and kinase-privileged fragments: toward virtual polypharmacology. J. Med. Chem., 2008, 51, 1214-1222. (Pubitemid 351480383)
-
(2008)
Journal of Medicinal Chemistry
, vol.51
, Issue.5
, pp. 1214-1222
-
-
Aronov, A.M.1
McClain, B.2
Moody, C.S.3
Murcko, M.A.4
-
137
-
-
1842690601
-
Molecular similarity searching using atom environments, information-based feature selection, and a naïve Bayesian classifier
-
Bender, A.; Mussa, H.Y.; Glen, R.C.; Reiling, S. Molecular similarity searching using atom environments, information-based feature selection, and a naïve Bayesian classifier. J. Chem. Inf. Comput. Sci., 2004, 44, 170-178.
-
(2004)
J. Chem. Inf. Comput. Sci.
, vol.44
, pp. 170-178
-
-
Bender, A.1
Mussa, H.Y.2
Glen, R.C.3
Reiling, S.4
-
138
-
-
0036628547
-
a, and logD
-
DOI 10.1021/ci010315d
-
Xing, L.; Glen, R.C. Novel methods for the prediction of logP, pK(a), and logD. J. Chem. Inf. Comput. Sci., 2002, 42, 796-805. (Pubitemid 35355228)
-
(2002)
Journal of Chemical Information and Computer Sciences
, vol.42
, Issue.4
, pp. 796-805
-
-
Xing, L.1
Glen, R.C.2
-
139
-
-
23844449940
-
Computer-based de novo design of drug-like molecules
-
DOI 10.1038/nrd1799
-
Schneider, G.; Fechner, U. Computer-based de novo design of drug-like molecules. Nat. Rev. Drug Discov., 2005, 4, 649-663. (Pubitemid 41149759)
-
(2005)
Nature Reviews Drug Discovery
, vol.4
, Issue.8
, pp. 649-663
-
-
Schneider, G.1
Fechner, U.2
-
140
-
-
33845379303
-
Atom pairs as molecular features in structure-activity studies: Definition and applications
-
Carhart, R.E.; Smith, D.H.; Venkataraghavan, R. Atom pairs as molecular features in structure-activity studies: definition and applications. J. Chem. Inf. Comput. Sci., 1985, 25, 64-73.
-
(1985)
J. Chem. Inf. Comput. Sci.
, vol.25
, pp. 64-73
-
-
Carhart, R.E.1
Smith, D.H.2
Venkataraghavan, R.3
-
141
-
-
3242672755
-
Approaches to target class combinatorial library design
-
Schnur, D.; Beno, B.R.; Good, A.; Tebben, A. Approaches to target class combinatorial library design. Methods Mol. Biol., 2004, 275, 355-378.
-
(2004)
Methods Mol. Biol.
, vol.275
, pp. 355-378
-
-
Schnur, D.1
Beno, B.R.2
Good, A.3
Tebben, A.4
-
142
-
-
33644839988
-
Diversity-oriented syn
-
thesis: exploring the intersections between chemistry and biology
-
Tan, D.S. Diversity-oriented synthesis: exploring the intersections between chemistry and biology. Nat. Chem. Biol., 2005, 1, 74-84.
-
(2005)
Nat. Chem. Biol.
, vol.1
, pp. 74-84
-
-
Tan, D.S.1
-
143
-
-
0001577643
-
Chemical similarity using physiochemical property descriptors
-
Kearsley, S.K.; Sallamack, S.; Fluder, E.M.; Andose, J.D.; Mosley, R.T.; Sheridan, R.P. Chemical similarity using physiochemical property descriptors. J. Chem. Inf. Comput. Sci., 1996, 36, 118-127. (Pubitemid 126579143)
-
(1996)
Journal of Chemical Information and Computer Sciences
, vol.36
, Issue.1
, pp. 118-127
-
-
Kearsley, S.K.1
Sallamack, S.2
Fluder, E.M.3
Andose, J.D.4
Mosley, R.T.5
Sheridan, R.P.6
-
144
-
-
0002820943
-
SPROUT, HIPPO and CAESA: Tools for de novo structure generation and estimation of synthetic accessibility
-
Gillet, V.J.; Myatt, G.; Zsoldos, Z.; Johnson, A.P. SPROUT, HIPPO and CAESA: tools for de novo structure generation and estimation of synthetic accessibility. Perspect. Drug Discov., 1995, 3, 34-50.
-
(1995)
Perspect. Drug Discov.
, vol.3
, pp. 34-50
-
-
Gillet, V.J.1
Myatt, G.2
Zsoldos, Z.3
Johnson, A.P.4
-
145
-
-
5444258821
-
Information content in organic molecules: Quantification and statistical structure via Brownian processing
-
Graham, D.J.; Malarkey, C.; Schulmerich, M.V. Information content in organic molecules: quantification and statistical structure via Brownian processing. J. Chem. Inf. Comput. Sci., 2004, 44, 1601-1611.
-
(2004)
J. Chem. Inf. Comput. Sci.
, vol.44
, pp. 1601-1611
-
-
Graham, D.J.1
Malarkey, C.2
Schulmerich, M.V.3
-
146
-
-
33750381015
-
Assessment of molecular similarity from the analysis of randomly generated structural fragment populations
-
DOI 10.1021/ci0601261
-
Batista, J.; Godden, J.W.; Bajorath, J. Assessment of molecular similarity from the analysis of randomly generated structural fragment populations. J. Chem. Inf. Model., 2006, 46, 1937-1944. (Pubitemid 44625965)
-
(2006)
Journal of Chemical Information and Modeling
, vol.46
, Issue.5
, pp. 1937-1944
-
-
Batista, J.1
Godden, J.W.2
Bajorath, J.3
-
147
-
-
34547678010
-
Mining of randomly generated molecular fragment populations uncovers activity-specific fragment hierarchies
-
DOI 10.1021/ci700108q
-
Batista, J.; Bajorath, J. Mining of randomly generated molecular fragment populations uncovers activity-specific fragment hierarchies. J. Chem. Inf. Model., 2007, 47, 1405-1413. (Pubitemid 47210044)
-
(2007)
Journal of Chemical Information and Modeling
, vol.47
, Issue.4
, pp. 1405-1413
-
-
Batista, J.1
Bajorath, J.2
-
148
-
-
37249031865
-
Mapping of activity-specific fragment pathways isolated from random fragment populations reveals the formation of coherent molecular cores
-
DOI 10.1021/ci700251b
-
Lounkine, E.; Batista, J.; Bajorath, J. Mapping of activity-specific fragment pathways isolated from random fragment populations reveals the formation of coherent molecular cores. J. Chem. Inf. Model., 2007, 47, 2133-2139. (Pubitemid 350275079)
-
(2007)
Journal of Chemical Information and Modeling
, vol.47
, Issue.6
, pp. 2133-2139
-
-
Lounkine, E.1
Batista, J.2
Bajorath, J.3
-
149
-
-
33846881583
-
Chemical database mining through entropy-based molecular similarity assessment of randomly generated structural fragment populations
-
DOI 10.1021/ci600377m
-
Batista, J.; Bajorath, J. Chemical database mining through entropy-based molecular similarity assessment of randomly generated structural fragment populations. J. Chem. Inf. Model., 2007, 47, 59-68. (Pubitemid 46225560)
-
(2007)
Journal of Chemical Information and Modeling
, vol.47
, Issue.1
, pp. 59-68
-
-
Batista, J.1
Bajorath, J.2
-
150
-
-
54849163800
-
Random molecular fragment methods in computational medicinal chemistry
-
Lounkine, E.; Batista, J.; Bajorath, J. Random molecular fragment methods in computational medicinal chemistry. Curr. Med. Chem., 2008, 15, 2108-2121.
-
(2008)
Curr. Med. Chem.
, vol.15
, pp. 2108-2121
-
-
Lounkine, E.1
Batista, J.2
Bajorath, J.3
-
152
-
-
10344230435
-
Molecular similarity: A key technique in molecular informatics
-
Bender, A.; Glen, R.C. Molecular similarity: a key technique in molecular informatics. Org. Biomol. Chem., 2004, 2, 3204-3218.
-
(2004)
Org. Biomol. Chem.
, vol.2
, pp. 3204-3218
-
-
Bender, A.1
Glen, R.C.2
-
153
-
-
33846465344
-
Chemical diversity and biological activity
-
DOI 10.1016/j.ddtec.2006.12.007, PII S1740674906000801
-
Schuffenhauer, A.; Brown, N. Chemical diversity and biological activity. Drug Discov. Today Technol., 2006, 3, 387-395. (Pubitemid 46158394)
-
(2006)
Drug Discovery Today: Technologies
, vol.3
, Issue.4
, pp. 387-395
-
-
Schuffenhauer, A.1
Brown, N.2
-
154
-
-
33646242741
-
Assessing the scaffold diversity of screening libraries
-
Krier, M.; Bret, G.; Rognan, D. Assessing the scaffold diversity of screening libraries. J. Chem. Inf. Model., 2006, 46, 512-524.
-
(2006)
J. Chem. Inf. Model.
, vol.46
, pp. 512-524
-
-
Krier, M.1
Bret, G.2
Rognan, D.3
-
155
-
-
77249139237
-
Systematic analysis of public domain compound potency data identifies selective molecular scaffolds across druggable target families
-
Hu, Y.; Wassermann, A.M.; Lounkine, E.; Bajorath, J. Systematic analysis of public domain compound potency data identifies selective molecular scaffolds across druggable target families. J. Med. Chem., 2010, 53, 752-758.
-
(2010)
J. Med. Chem.
, vol.53
, pp. 752-758
-
-
Hu, Y.1
Wassermann, A.M.2
Lounkine, E.3
Bajorath, J.4
-
156
-
-
34247198331
-
Clustering and rule-based classifications of chemical structures evaluated in the biological activity space
-
DOI 10.1021/ci6004004
-
Schuffenhauer, A.; Brown, N.; Ertl, P.; Jenkins, J.L.; Selzer, P.; Hamon, J. Clustering and rule-based classifications of chemical structures evaluated in the biological activity space. J. Chem. Inf. Model., 2007, 47, 325-336. (Pubitemid 46615937)
-
(2007)
Journal of Chemical Information and Modeling
, vol.47
, Issue.2
, pp. 325-336
-
-
Schuffenhauer, A.1
Brown, N.2
Ertl, P.3
Jenkins, J.L.4
Selzer, P.5
Hamon, J.6
-
157
-
-
0347361638
-
Characteristic physical properties and structural fragments of marketed oral drugs
-
DOI 10.1021/jm030267j
-
Vieth, M.; Siegel, M.G.; Higgs, R.E.; Watson, I.A.; Robertson, D.H.; Savin, K.A.; Durst, G.L.; Hipskind, P.A. Characteristic physical properties and structural fragments of marketed oral drugs. J. Med. Chem., 2004, 47, 224-232. (Pubitemid 38040506)
-
(2004)
Journal of Medicinal Chemistry
, vol.47
, Issue.1
, pp. 224-232
-
-
Vieth, M.1
Siegel, M.G.2
Higgs, R.E.3
Watson, I.A.4
Robertson, D.H.5
Savin, K.A.6
Durst, G.L.7
Hipskind, P.A.8
-
158
-
-
0037498077
-
Use of recursion forests in the sequential screening process: Consensus selection by multiple recursion trees
-
van Rhee, A.M. Use of recursion forests in the sequential screening process: consensus selection by multiple recursion trees. J. Chem. Inf. Comput. Sci., 2003, 43, 941-948.
-
(2003)
J. Chem. Inf. Comput. Sci.
, vol.43
, pp. 941-948
-
-
Van Rhee, A.M.1
-
159
-
-
0034780805
-
Fragment-based flexible ligand docking by evolutionary optimization
-
DOI 10.1515/BC.2001.168
-
Budin, N.; Majeux, N.; Caflisch, A. Fragment-based flexible ligand docking by evolutionary optimization. Biol. Chem., 2001, 382, 1365-1372. (Pubitemid 32976495)
-
(2001)
Biological Chemistry
, vol.382
, Issue.9
, pp. 1365-1372
-
-
Budin, N.1
Majeux, N.2
Caflisch, A.3
-
160
-
-
0000424557
-
Intramolecular hydrogen bonds: Common motifs, probabilities of formation and implications for supramolecular organization
-
Bilton, C.; Allen, F.H.; Shields, G.P.; Howard, J.A. Intramolecular hydrogen bonds: common motifs, probabilities of formation and implications for supramolecular organization. Acta Crystallogr. B, 2000, 56, 849-856.
-
(2000)
Acta Crystallogr. B
, vol.56
, pp. 849-856
-
-
Bilton, C.1
Allen, F.H.2
Shields, G.P.3
Howard, J.A.4
-
161
-
-
79960695275
-
Databases and their use for studying intermolecular interactions
-
Martin, Y.C; Willett, P., Eds.; ACS: Washington, DC
-
Pitchford, N.A.; Taylor, R. Crystallographic Databases and Their Use for Studying Intermolecular Interactions. In: Designing Bioactive Molecules; Martin, Y.C; Willett, P., Eds.; ACS: Washington, DC, 1998; pp. 19-46.
-
(1998)
Designing Bioactive Molecules
, pp. 19-46
-
-
Pitchford, N.A.1
Taylor, R.2
-
162
-
-
12144254795
-
β-Diketo acid pharmacophore hypothesis. 1. Discovery of a novel class of HIV-1 integrase inhibitors
-
DOI 10.1021/jm0496077
-
Dayam, R.; Sanchez, T.; Clement, O.; Shoemaker, R.; Sei, S.; Neamati, N. β-Diketo acid pharmacophore hypothesis. 1. Discovery of a novel class of HIV-1 integrase inhibitors. J. Med. Chem., 2005, 48, 111-120. (Pubitemid 40105252)
-
(2005)
Journal of Medicinal Chemistry
, vol.48
, Issue.1
, pp. 111-120
-
-
Dayam, R.1
Sanchez, T.2
Clement, O.3
Shoemaker, R.4
Sei, S.5
Neamati, N.6
-
163
-
-
79953835779
-
HIV-1 in strand transfer chelating inhibitors: A focus on metal binding
-
Bacchi, A.; Carcelli, M.; Compari, C.; Fisicaro, E.; Pala, N.; Rispoli, G.; Rogolino, D.; Sanchez, T.W.; Sechi, M.; Neamati, N. HIV-1 IN strand transfer chelating inhibitors: a focus on metal binding. Mol. Pharm., 2011, 8, 507-519.
-
(2011)
. Mol. Pharm.
, vol.8
, pp. 507-519
-
-
Bacchi, A.1
Carcelli, M.2
Compari, C.3
Fisicaro, E.4
Pala, N.5
Rispoli, G.6
Rogolino, D.7
Sanchez, T.W.8
Sechi, M.9
Neamati, N.10
-
164
-
-
77956308900
-
Binding-site assessment by virtual fragment screening
-
Huang, N.; Jacobson, M.P. Binding-site assessment by virtual fragment screening. PLoS One, 2010, 5, e10109.
-
(2010)
PLoS One
, vol.5
-
-
Huang, N.1
Jacobson, M.P.2
-
165
-
-
34547691007
-
GPCR structure-based virtual screening approach for CB2 antagonist search
-
DOI 10.1021/ci7000814
-
Chen, J.Z.; Wang, J.; Xie, X.Q. GPCR structure-based virtual screening approach for CB2 antagonist search. J. Chem. Inf. Model., 2007, 47, 1626-1637. (Pubitemid 47210066)
-
(2007)
Journal of Chemical Information and Modeling
, vol.47
, Issue.4
, pp. 1626-1637
-
-
Chen, J.-Z.1
Wang, J.2
Xie, X.-Q.3
-
166
-
-
84860510662
-
Role of natural products in drug discovery
-
Rankovic, Z.; Morphy, R., Eds.; John Wiley & Sons: New York
-
Lachance, H.; Wetzel, S.; Waldmann H. Role of natural products in drug discovery. In: Lead Generation Approaches in Drug Discovery; Rankovic, Z.; Morphy, R., Eds.; John Wiley & Sons: New York, 2010; pp. 187-229.
-
(2010)
Lead Generation Approaches in Drug Discovery
, pp. 187-229
-
-
Lachance, H.1
Wetzel, S.2
Waldmann, H.3
-
167
-
-
39149137869
-
Plant-derived compounds in clinical trials
-
Saklani, A.; Kutty, S.K. Plant-derived compounds in clinical trials. Drug Discov. Today, 2008, 13, 161-171.
-
(2008)
Drug Discov. Today
, vol.13
, pp. 161-171
-
-
Saklani, A.1
Kutty, S.K.2
-
168
-
-
42949149681
-
Modern natural products chemistry and drug discovery
-
DOI 10.1021/jm701291u
-
Ojima, I. Modern natural products chemistry and drug discovery. J. Med. Chem., 2008, 51, 2587-2588. (Pubitemid 351620777)
-
(2008)
Journal of Medicinal Chemistry
, vol.51
, Issue.9
, pp. 2587-2588
-
-
Ojima, I.1
-
169
-
-
0035347869
-
Scaffold architecture and pharmacophoric properties of natural products and trade drugs: Application in the design of natural product-based combinatorial libraries
-
DOI 10.1021/cc000097l
-
Lee, M.L.; Schneider, G. Scaffold architecture and pharmacophoric properties of natural products and trade drugs: application in the design of natural product-based combinatorial libraries. J. Comb. Chem., 2001, 3, 284-289. (Pubitemid 33616450)
-
(2001)
Journal of Combinatorial Chemistry
, vol.3
, Issue.3
, pp. 284-289
-
-
Lee, M.-L.1
Schneider, G.2
-
170
-
-
0037208308
-
Property distributions: Differences between drugs, natural products, and molecules from combinatorial chemistry
-
Feher, M.; Schmidt, J.M. Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry. J. Chem. Inf. Comput. Sci., 2003, 43, 218-227.
-
(2003)
J. Chem. Inf. Comput. Sci.
, vol.43
, pp. 218-227
-
-
Feher, M.1
Schmidt, J.M.2
-
171
-
-
67349190954
-
The chemist as astronaut: Searching for biologically useful space in the chemical universe
-
Triggle, D.J. The chemist as astronaut: searching for biologically useful space in the chemical universe. Biochem. Pharmacol., 2009, 78, 217-223.
-
(2009)
Biochem. Pharmacol.
, vol.78
, pp. 217-223
-
-
Triggle, D.J.1
-
172
-
-
42949115495
-
Cheminformatics analysis of natural products: Lessons from nature inspiring the design of new drugs
-
Ertl, P.; Schuffenhauer, A. Cheminformatics analysis of natural products: lessons from nature inspiring the design of new drugs. Prog. Drug Res., 2008, 66, 217,219-235.
-
(2008)
Prog. Drug Res.
, vol.66
, Issue.217
, pp. 219-235
-
-
Ertl, P.1
Schuffenhauer, A.2
-
173
-
-
52649134945
-
Scaffold diversity of natural products: Inspiration for combinatorial library design
-
Grabowski, K.; Baringhaus, K.H.; Schneider, G. Scaffold diversity of natural products: inspiration for combinatorial library design. Nat. Prod. Rep., 2008, 25, 892-904.
-
(2008)
Nat. Prod. Rep.
, vol.25
, pp. 892-904
-
-
Grabowski, K.1
Baringhaus, K.H.2
Schneider, G.3
-
174
-
-
77957920721
-
Chemical space as a source for new drugs
-
Reymond, J.L; van Deursen, R.; Blum, L.C.; Ruddigkeit, L. Chemical space as a source for new drugs. Medchemcomm, 2010, 1, 30-38.
-
(2010)
Medchemcomm
, vol.1
, pp. 30-38
-
-
Reymond, J.L.1
Van Deursen, R.2
Blum, L.C.3
Ruddigkeit, L.4
-
175
-
-
0002169158
-
Knowledge discovery in databases: An overview
-
Frawley, W.J.; Piatetsky-Shapiro, G.; Matheus, C.J. Knowledge discovery in databases: an overview. AI Magazine, 1992, 13, 57-70.
-
(1992)
AI Magazine
, vol.13
, pp. 57-70
-
-
Frawley, W.J.1
Piatetsky-Shapiro, G.2
Matheus, C.J.3
-
176
-
-
0002283033
-
From data mining to knowledge discovery in databases
-
Fayyad, U.; Piatetsky-Shapiro, G.; Smyth, P. From data mining to knowledge discovery in databases. AI Magazine, 1996, 17, 37-54.
-
(1996)
AI Magazine
, vol.17
, pp. 37-54
-
-
Fayyad, U.1
Piatetsky-Shapiro, G.2
Smyth, P.3
-
177
-
-
79960674168
-
Mapping fragmental druglikeness in the MoStBioDat environment: Intramolecular hydrogen bonding motifs in β -ketoenols
-
Bak, A.; Magdziarz, T.; Kurczyk, A.; Polanski, J. Mapping fragmental druglikeness in the MoStBioDat environment: intramolecular hydrogen bonding motifs in β -ketoenols. Comb. Chem. High Throughput Screen., 2011, 14, 560-569.
-
(2011)
Comb. Chem. High Throughput Screen.
, vol.14
, pp. 560-569
-
-
Bak, A.1
Magdziarz, T.2
Kurczyk, A.3
Polanski, J.4
-
178
-
-
61949359014
-
Common pharmacophore identification using frequent clique detection algorithm
-
Podolyan, Y.; Karypis, G. Common pharmacophore identification using frequent clique detection algorithm. J. Chem. Inf. Model., 2009, 49, 13-21.
-
(2009)
J. Chem. Inf. Model.
, vol.49
, pp. 13-21
-
-
Podolyan, Y.1
Karypis, G.2
-
179
-
-
77957233085
-
From structure diagrams to visual chemical patterns
-
Schomburg, K.; Ehrlich, H.C.; Stierand, K.; Rarey, M. From structure
-
(2010)
J. Chem. Inf. Model.
, vol.50
, pp. 1529-1535
-
-
Schomburg, K.1
Ehrlich, H.C.2
Stierand, K.3
Rarey, M.4
-
180
-
-
0024664539
-
SMILES. 2. Algorithm for generation of unique SMILES notation
-
Weininger, D.; Weininger, A.; Weininger, J.L. SMILES. 2. Algorithm for generation of unique SMILES notation. J. Chem. Inf. Comput. Sci., 1989, 29, 97-101.
-
(1989)
J. Chem. Inf. Comput. Sci.
, vol.29
, pp. 97-101
-
-
Weininger, D.1
Weininger, A.2
Weininger, J.L.3
-
181
-
-
0000010226
-
Novel canonical coding method for representation of three-dimensional structures
-
Satoh, H.; Koshin, H.; Funatsu, K.; Nakata, T. Novel canonical coding method for representation of three-dimensional structures. J. Chem. Inf. Comput. Sci., 2000, 40, 622-630.
-
(2000)
J. Chem. Inf. Comput. Sci.
, vol.40
, pp. 622-630
-
-
Satoh, H.1
Koshin, H.2
Funatsu, K.3
Nakata, T.4
-
182
-
-
77954684593
-
Design of chemical libraries with potentially bioactive molecules applying a maximum common substructure concept
-
Lisurek, M.; Rupp, B.; Wichard, J.; Neuenschwander, M.; von Kries, J.P.; Frank, R.; Rademann, J.; Kuhne, R. Design of chemical libraries with potentially bioactive molecules applying a maximum common substructure concept. Mol. Divers., 2010, 14, 401-408.
-
(2010)
Mol. Divers.
, vol.14
, pp. 401-408
-
-
Lisurek, M.1
Rupp, B.2
Wichard, J.3
Neuenschwander, M.4
Von Kries, J.P.5
Frank, R.6
Rademann, J.7
Kuhne, R.8
-
183
-
-
62549107911
-
Quinolone antibiotics: The development of moxifloxacin
-
Fischer, J.; Ganellin, C.R., Eds.; Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim
-
Petersen, U. Quinolone Antibiotics: The Development of Moxifloxacin. In: Analogue-Based Drug Discovery; Fischer, J.; Ganellin, C.R., Eds.; Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim, 2006; pp. 315-370.
-
(2006)
Analogue-Based Drug Discovery
, pp. 315-370
-
-
Petersen, U.1
-
184
-
-
14844326683
-
Evaluation of French Guiana traditional antimalarial remedies
-
DOI 10.1016/j.jep.2004.12.020
-
Bertani, S.; Bourdy, G.; Landau, I.; Robinson, J.C.; Esterre, P.; Deharo, E. Evaluation of French Guiana traditional antimalarial remedies. J. Ethnopharmacol., 2005, 98, 45-54. (Pubitemid 40349166)
-
(2005)
Journal of Ethnopharmacology
, vol.98
, Issue.1-2
, pp. 45-54
-
-
Bertani, S.1
Bourdy, G.2
Landau, I.3
Robinson, J.C.4
Esterre, Ph.5
Deharo, E.6
-
185
-
-
28244468426
-
Synthesis and biological activity of fatty acid derivatives of quinine
-
DOI 10.1271/bbb.69.2250
-
Kumura, N.; Izumi, M.; Nakajima, S.; Shimizu, S.; Kim, H.S.; Wataya, Y.; Baba, N. Synthesis and biological activity of fatty acid derivatives of quinine. Biosci. Biotechnol. Biochem., 2005, 69, 2250-2253. (Pubitemid 41711855)
-
(2005)
Bioscience, Biotechnology and Biochemistry
, vol.69
, Issue.11
, pp. 2250-2253
-
-
Kumura, N.1
Izumi, M.2
Nakajima, S.3
Shimizu, S.4
Kim, H.-S.5
Wataya, Y.6
Baba, N.7
-
186
-
-
77955624545
-
A brief history of malaria chemotherapy
-
Butler, A.; Khan, S.; Ferguson, E. A brief history of malaria chemotherapy. J. R. Coll. Physicians Edinb., 2010, 40, 172-177.
-
(2010)
J. R. Coll. Physicians Edinb.
, vol.40
, pp. 172-177
-
-
Butler, A.1
Khan, S.2
Ferguson, E.3
-
187
-
-
78650438094
-
The reality of using primaquine
-
Burgoine, K.L.; Bancone, G.; Nosten, F. The reality of using primaquine. Malar. J., 2010, 9, 376.
-
(2010)
Malar. J.
, vol.9
, pp. 376
-
-
Burgoine, K.L.1
Bancone, G.2
Nosten, F.3
-
188
-
-
3042767495
-
Ferroquine: A new weapon in the fight against malaria
-
DOI 10.2174/1568012043354008
-
Biot, C. Ferroquine: a new weapon in the fight against malaria. Curr. Med. Chem.: Anti-Infect. Agents, 2004, 3, 135-147. (Pubitemid 38864706)
-
(2004)
Current Medicinal Chemistry: Anti-Infective Agents
, vol.3
, Issue.2
, pp. 135-147
-
-
Biot, C.1
-
189
-
-
3042762533
-
Quinine sulfate and HSV replication
-
Wolf, R.; Baroni, A.; Greco, R.; Corrado, F.; Ruocco, E.; Tufano, M.A.; Ruocco, V. Quinine sulfate and HSV replication. Dermatol. Online J., 2003, 9, 3.
-
(2003)
Dermatol. Online J.
, vol.9
, pp. 3
-
-
Wolf, R.1
Baroni, A.2
Greco, R.3
Corrado, F.4
Ruocco, E.5
Tufano, M.A.6
Ruocco, V.7
-
190
-
-
33644841699
-
Screening for antimicrobial activity of ten medicinal plants used in Colombian folkloric medicine: A possible alternative in the treatment of non-nosocomial infections
-
Rojas, J.J.; Ochoa, V.J.; Ocampo, S.A.; Munoz, J.F.; Screening for antimicrobial activity of ten medicinal plants used in Colombian folkloric medicine: a possible alternative in the treatment of non-nosocomial infections. BMC Complement. Altern. Med., 2006, 6, 2.
-
(2006)
BMC Complement. Altern. Med.
, vol.6
, pp. 2
-
-
Rojas, J.J.1
Ochoa, V.J.2
Ocampo, S.A.3
Munoz, J.F.4
-
191
-
-
84860542236
-
Quinoline scaffold as a privileged substructure in antimicrobial drugs
-
Mendez-Vilas, A., Ed.; Formatex Research Center
-
Musiol, R.; Magdziarz, T.; Kurczyk, A. Quinoline scaffold as a privileged substructure in antimicrobial drugs. In: Science against microbial pathogens: communicating current research and technological advances; Mendez-Vilas, A., Ed.; Formatex Research Center, 2011; pp. 72-83.
-
(2011)
Science Against Microbial Pathogens: Communicating Current Research and Technological Advances
, pp. 72-83
-
-
Musiol, R.1
Magdziarz, T.2
Kurczyk, A.3
-
192
-
-
62949190997
-
Muscle cramps - Differential diagnosis and therapy
-
Reichel, G. Muscle cramps - differential diagnosis and therapy. Med. Monatsschr. Pharm., 2009, 32, 80-86.
-
(2009)
Med. Monatsschr. Pharm.
, vol.32
, pp. 80-86
-
-
Reichel, G.1
-
193
-
-
0027453395
-
Quinine-induced hypoglycemia
-
Limburg, P.J.; Katz, H.; Grant, C.S.; Service, F.J. Quinine-induced hypoglycemia. Ann. Intern. Med. 1993, 119, 218-219. (Pubitemid 23327622)
-
(1993)
Annals of Internal Medicine
, vol.119
, Issue.3
, pp. 218-219
-
-
Limburg, P.J.1
Katz, H.2
Grant, C.S.3
Service, F.J.4
-
194
-
-
59749100769
-
Role of late sodium current in modulating the proarrhythmic and antiarrhythmic effects of quinidine
-
Wu, L.; Guo, D.; Li, H.; Hackett, J.; Yan, G.X.; Jiao, Z.; Antzelevitch, C.; Shryock, J.C.; Belardinelli, L. Role of late sodium current in modulating the proarrhythmic and antiarrhythmic effects of quinidine. Heart Rhythm, 2008, 5, 1726-1734.
-
(2008)
Heart Rhythm
, vol.5
, pp. 1726-1734
-
-
Wu, L.1
Guo, D.2
Li, H.3
Hackett, J.4
Yan, G.X.5
Jiao, Z.6
Antzelevitch, C.7
Shryock, J.C.8
Belardinelli, L.9
-
195
-
-
34250778472
-
Die Jagd auf Chinin: Etappenerfolge und Gesamtsiege
-
Kaufman, T.S.; Ruveda, E.A. Die Jagd auf Chinin: Etappenerfolge und Gesamtsiege. Angew. Chem., 2005, 117, 876-907.
-
(2005)
Angew. Chem.
, vol.117
, pp. 876-907
-
-
Kaufman, T.S.1
Ruveda, E.A.2
-
196
-
-
79851474042
-
Is chloroquine making a comeback?
-
Hand, C.C.; Meshnick, S.R. Is chloroquine making a comeback? J. Infect. Dis., 2011, 203, 11-12.
-
(2011)
J. Infect. Dis.
, vol.203
, pp. 11-12
-
-
Hand, C.C.1
Meshnick, S.R.2
-
197
-
-
79551704495
-
Hospitalization of Cuban children for giardiasis: A retrospective study in a pediatric hospital in Havana
-
Escobedo, A.A.; Almirall, P.; Alfonso, M.; Salazar, Y.; Avila, I.; Cimerman, S.; Nunez, F.A.; Dawkins, I.V. Hospitalization of Cuban children for giardiasis: a retrospective study in a pediatric hospital in Havana. Ann. Trop. Med. Parasitol., 2011, 105, 47-56.
-
(2011)
Ann. Trop. Med. Parasitol.
, vol.105
, pp. 47-56
-
-
Escobedo, A.A.1
Almirall, P.2
Alfonso, M.3
Salazar, Y.4
Avila, I.5
Cimerman, S.6
Nunez, F.A.7
Dawkins, I.V.8
-
198
-
-
0021633432
-
Norfloxacin - a review of pharmacology and tissue penetration
-
Wise, R. Norfloxacin - a review of pharmacology and tissue penetration. J. Antimicrob. Chemother., 1984, 13 Suppl B, 59-64. (Pubitemid 15075781)
-
(1984)
Journal of Antimicrobial Chemotherapy
, vol.13
, Issue.SUPPL. B
, pp. 59-64
-
-
Wise, R.1
-
199
-
-
0038778607
-
The quinolones: Decades of development and use
-
Emmerson, A.M.; Jones, A.M. The quinolones: decades of development and use. J. Antimicrob. Chemother., 2003, 51 Suppl 1, 13-20. (Pubitemid 36622100)
-
(2003)
Journal of Antimicrobial Chemotherapy
, vol.51
, Issue.SUPPL. 1
, pp. 13-20
-
-
Emmerson, A.M.1
Jones, A.M.2
-
200
-
-
0024997687
-
Demonstration of quinolone phototoxicity in vitro
-
Przybilla, B.; Georgii, A.; Bergner, T.; Ring, J. Demonstration of quinolone phototoxicity in vitro. Dermatologica, 1990, 181, 98-103. (Pubitemid 20263275)
-
(1990)
Dermatologica
, vol.181
, Issue.2
, pp. 98-103
-
-
Przybilla, B.1
Georgii, A.2
Bergner, T.3
Ring, J.4
-
201
-
-
0032971470
-
Expanded activity and utility of the new fluoroquinolones: A review
-
DOI 10.1016/S0149-2918(00)88266-1
-
Blondeau, J.M. Expanded activity and utility of the new fluoroquinolones: a review. Clin. Ther., 1999, 21, 3-40. (Pubitemid 29106688)
-
(1999)
Clinical Therapeutics
, vol.21
, Issue.1
, pp. 3-40
-
-
Blondeau, J.M.1
-
202
-
-
70350726100
-
The newer fluoroquinolones
-
Bolon, M.K. The newer fluoroquinolones. Infect. Dis. Clin. North Am., 2009, 23, 1027-1051.
-
(2009)
Infect. Dis. Clin. North Am.
, vol.23
, pp. 1027-1051
-
-
Bolon, M.K.1
-
203
-
-
33745016515
-
Pharmacology of the fluoroquinolones: A perspective for the use in domestic animals
-
DOI 10.1016/j.tvjl.2005.07.010, PII S1090023305001814
-
Martinez, M.; McDermott, P.; Walker, R. Pharmacology of the fluoroquinolones: a perspective for the use in domestic animals. Vet. J., 2006, 172, 10-28. (Pubitemid 43869434)
-
(2006)
Veterinary Journal
, vol.172
, Issue.1
, pp. 10-28
-
-
Martinez, M.1
McDermott, P.2
Walker, R.3
-
204
-
-
21844444791
-
Antimicrobial safety: Focus on fluoroquinolones
-
Owens, R.C.; Ambrose, P.G. Antimicrobial safety: focus on fluoroquinolones. Clin. Infect. Dis., 2005, 41 Suppl 2, S144-157. (Pubitemid 40962485)
-
(2005)
Clinical Infectious Diseases
, vol.41
, Issue.SUPPL.
-
-
Owens Jr., R.C.1
Ambrose, P.G.2
-
205
-
-
80053477373
-
The use of systemic and topical fluoroquinolones
-
Bradley, J.S.; Jackson, M.A. The use of systemic and topical fluoroquinolones. Pediatrics, 2011, 128, e1034-1045.
-
(2011)
Pediatrics
, vol.128
-
-
Bradley, J.S.1
Jackson, M.A.2
-
206
-
-
0344825065
-
Development of fluoroquinolones as first-line drugs for tuberculosis - At long last!
-
O'Brien, R.J. Development of fluoroquinolones as first-line drugs for tuberculosis - at long last! Am. J. Respir. Crit. Care Med., 2003, 168, 1266-1268.
-
(2003)
Am. J. Respir. Crit. Care Med.
, vol.168
, pp. 1266-1268
-
-
O'brien, R.J.1
-
207
-
-
77954688186
-
6-desfluoroquinolones as HIV-1 Tat-mediated transcription inhibitors
-
Tabarrini, O.; Massari, S.; Cecchetti, V. 6-desfluoroquinolones as HIV-1 Tat-mediated transcription inhibitors. Future Med. Chem., 2010, 2, 1161-1180.
-
(2010)
Future Med. Chem.
, vol.2
, pp. 1161-1180
-
-
Tabarrini, O.1
Massari, S.2
Cecchetti, V.3
-
208
-
-
67651047155
-
The 4-quinolone-3-carboxylic acid motif as a multivalent scaffold in medicinal chemistry
-
Mugnaini, C.; Pasquini, S.; Corelli, F. The 4-quinolone-3-carboxylic acid motif as a multivalent scaffold in medicinal chemistry. Curr. Med. Chem., 2009, 16, 1746-1767.
-
(2009)
Curr. Med. Chem.
, vol.16
, pp. 1746-1767
-
-
Mugnaini, C.1
Pasquini, S.2
Corelli, F.3
-
209
-
-
27744586780
-
Endovascular treatment of cerebral vasospasm: Transluminal balloon angioplasty, intra-arterial papaverine, and intra-arterial nicardipine
-
DOI 10.1016/j.nec.2005.04.004, PII S1042368005000264
-
Hoh, B.L.; Ogilvy, C.S. Endovascular treatment of cerebral vasospasm: transluminal balloon angioplasty, intra-arterial papaverine, and intra-arterial nicardipine. Neurosurg. Clin. N. Am., 2005, 16, 501-516. (Pubitemid 41766378)
-
(2005)
Neurosurgery Clinics of North America
, vol.16
, Issue.3
, pp. 501-516
-
-
Hoh, B.L.1
Ogilvy, C.S.2
-
210
-
-
24644465551
-
Intra-arterial papaverine infusions for the treatment of cerebral vasospasm induced by aneurysmal subarachnoid hemorrhage
-
DOI 10.1385/NCC:2:2:124
-
Liu, J.K.; Couldwell, W.T. Intra-arterial papaverine infusions for the treatment of cerebral vasospasm induced by aneurysmal subarachnoid hemorrhage. Neurocrit. Care, 2005, 2, 124-132. (Pubitemid 41270855)
-
(2005)
Neurocritical Care
, vol.2
, Issue.2
, pp. 124-132
-
-
Liu, J.K.1
Couldwell, W.T.2
-
211
-
-
33750587743
-
Endovascular treatment strategies for cerebral vasospasm
-
Mindea, S.A.; Yang, B.P.; Bendok, B.R.; Miller, J.W.; Batjer, H.H. Endovascular treatment strategies for cerebral vasospasm. Neurosurg. Focus, 2006, 21, E13.
-
(2006)
Neurosurg. Focus
, vol.21
-
-
Mindea, S.A.1
Yang, B.P.2
Bendok, B.R.3
Miller, J.W.4
Batjer, H.H.5
-
212
-
-
33750476339
-
Neurointerventional treatment of vasospasm
-
DOI 10.1179/016164106X152043
-
Brisman, J.L.; Eskridge, J.M.; Newell, D.W. Neurointerventional treatment of vasospasm. Neurol. Res., 2006, 28, 769-776. (Pubitemid 44656103)
-
(2006)
Neurological Research
, vol.28
, Issue.7
, pp. 769-776
-
-
Brisman, J.L.1
Eskridge, J.M.2
Newell, D.W.3
-
213
-
-
27744542228
-
Available and future treatments for erectile dysfunction
-
Dinsmore, W.W. Available and future treatments for erectile dysfunction. Clin. Cornerstone, 2005, 7, 37-45.
-
(2005)
Clin. Cornerstone
, vol.7
, pp. 37-45
-
-
Dinsmore, W.W.1
-
214
-
-
23744435642
-
A comparative review of the options for treatment of erectile dysfunction: Which treatment for which patient?
-
DOI 10.2165/00003495-200565120-00003
-
Hatzimouratidis, K.; Hatzichristou, D.G. A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient? Drugs, 2005, 65, 1621-1650. (Pubitemid 41138985)
-
(2005)
Drugs
, vol.65
, Issue.12
, pp. 1621-1650
-
-
Hatzimouratidis, K.1
Hatzichristou, D.G.2
-
215
-
-
70349404397
-
Quinaprilat: A review of its pharmacokinetics, pharmacodynamics, toxicological data and clinical application
-
Kieback, A.G.; Felix, S.B.; Reffelmann, T. Quinaprilat: a review of its pharmacokinetics, pharmacodynamics, toxicological data and clinical application. Expert Opin. Drug. Metab. Toxicol., 2009, 5, 1337-1347.
-
(2009)
Expert Opin. Drug. Metab. Toxicol.
, vol.5
, pp. 1337-1347
-
-
Kieback, A.G.1
Felix, S.B.2
Reffelmann, T.3
-
216
-
-
80052674928
-
Gefitinib in non small cell lung cancer
-
Costanzo, R.; Piccirillo, M.C.; Sandomenico, C.; Carillio, G.; Montanino, A.; Daniele, G.; Giordano, P.; Bryce, J.; Feo, G.D.; Di Maio, M.; Rocco, G.; Normanno, N.; Perrone, F.; Morabito, A. Gefitinib in non small cell lung cancer. J. Biomed. Biotechnol., 2011, 2011, 815269.
-
(2011)
J. Biomed. Biotechnol.
, vol.2011
, pp. 815269
-
-
Costanzo, R.1
Piccirillo, M.C.2
Sandomenico, C.3
Carillio, G.4
Montanino, A.5
Daniele, G.6
Giordano, P.7
Bryce, J.8
Feo, G.D.9
Di Maio, M.10
Rocco, G.11
Normanno, N.12
Perrone, F.13
Morabito, A.14
-
217
-
-
79955919708
-
Clinical pharmacokinetics of tyrosine kinase inhibitors: Focus on 4-anilinoquinazolines
-
Scheffler, M.; Gion, P.D; Doroshyenko, O.; Wolf, J.; Fuhr, U. Clinical pharmacokinetics of tyrosine kinase inhibitors: focus on 4-anilinoquinazolines. Clin. Pharmacokinet., 2011, 50, 371-403.
-
(2011)
Clin. Pharmacokinet.
, vol.50
, pp. 371-403
-
-
Scheffler, M.1
Gion, P.D.2
Doroshyenko, O.3
Wolf, J.4
Fuhr, U.5
-
218
-
-
77957335553
-
Gefitinib or erlotinib in the treatment of advanced non-small cell lung cancer
-
Shao, Y.Y.; Lin, C.C.; Yang, C.H. Gefitinib or erlotinib in the treatment of advanced non-small cell lung cancer. Discov. Med., 2010, 9, 538-545.
-
(2010)
Discov. Med.
, vol.9
, pp. 538-545
-
-
Shao, Y.Y.1
Lin, C.C.2
Yang, C.H.3
-
219
-
-
79960192285
-
Phospshoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitors: Discovery and structure-activity relationships of a series of quinoline and quinoxaline derivatives
-
Nishimura, N.; Siegmund, A.; Liu, L.; Yang, K.; Bryan, M.C.; Andrews, K.L.; Bo, Y.; Booker, S.K.; Caenepeel, S.; Freeman, D.; Liao, H.; McCarter, J.; Mullady, E.L.; San Miguel, T.; Subramanian, R.; Tamayo, N.; Wang, L.; Whittington, D.A.; Zalameda, L.; Zhang, N.; Hughes, P.E.; Norman, M.H. Phospshoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitors: discovery and structure-activity relationships of a series of quinoline and quinoxaline derivatives. J. Med. Chem., 2011, 54, 4735-4751.
-
(2011)
J. Med. Chem.
, vol.54
, pp. 4735-4751
-
-
Nishimura, N.1
Siegmund, A.2
Liu, L.3
Yang, K.4
Bryan, M.C.5
Andrews, K.L.6
Bo, Y.7
Booker, S.K.8
Caenepeel, S.9
Freeman, D.10
Liao, H.11
McCarter, J.12
Mullady, E.L.13
San Miguel, T.14
Subramanian, R.15
Tamayo, N.16
Wang, L.17
Whittington, D.A.18
Zalameda, L.19
Zhang, N.20
Hughes, P.E.21
Norman, M.H.22
more..
-
220
-
-
60449108971
-
Structure-activity studies of echinomycin antibiotics against drug-resistant and biofilm-forming Staphylococcus aureus and Enterococcus faecalis
-
Socha, A.M.; Laplante, K.L.; Russell, D.J.; Rowley, D.C. Structure-activity studies of echinomycin antibiotics against drug-resistant and biofilm-forming Staphylococcus aureus and Enterococcus faecalis. Bioorg. Med. Chem., 2009, 19, 1504-1507.
-
(2009)
Bioorg. Med. Chem.
, vol.19
, pp. 1504-1507
-
-
Socha, A.M.1
Laplante, K.L.2
Russell, D.J.3
Rowley, D.C.4
-
221
-
-
33645129089
-
Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms
-
Sandoe, J.A.T.; Wysome, J.; West, A.P.; Heritage, J.; Wilcox, M.H. Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms. J. Antimicrob. Chemother., 2006, 57, 767-770.
-
(2006)
J. Antimicrob. Chemother.
, vol.57
, pp. 767-770
-
-
Sandoe, J.A.T.1
Wysome, J.2
West, A.P.3
Heritage, J.4
Wilcox, M.H.5
-
222
-
-
8844258137
-
In vitro antibacterial activity of echinomycin and a novel analogue, YK2000, against vancomycin-resistant enterococci
-
DOI 10.1016/j.ijantimicag.2004.03.018, PII S0924857904001803
-
Kim, J.B.; Lee, G.S.; Kim, Y.B.; Kim, S.K.; Kim, Y.H.; In vitro antibacterial activity of echinomycin and a novel analogue, YK2000, against vancomycinresistant enterococci. Int. J. Antimicrob. Agents, 2004, 24, 613-615. (Pubitemid 39536119)
-
(2004)
International Journal of Antimicrobial Agents
, vol.24
, Issue.6
, pp. 613-615
-
-
Kim, J.-B.1
Lee, G.-S.2
Kim, Y.-B.3
Kim, S.-K.4
Kim, Y.H.5
-
223
-
-
84856120428
-
A Comparison of Dequalinium Chloride Vaginal Tablets (Fluomizin®) and Clindamycin Vaginal Cream in the Treatment of Bacterial Vaginosis: A Single-Blind, Randomized Clinical Trial of Efficacy and Safety
-
Epub ahead of print
-
Weissenbacher, E.R.; Donders, G.; Unzeitig, V.; Martinez de Tejada, B.; Gerber, S.; Halaska, M.; Spacek, J. A Comparison of Dequalinium Chloride Vaginal Tablets (Fluomizin®) and Clindamycin Vaginal Cream in the Treatment of Bacterial Vaginosis: A Single-Blind, Randomized Clinical Trial of Efficacy and Safety. Gynecol. Obstet. Invest., 2012, Epub ahead of print.
-
(2012)
Gynecol. Obstet. Invest.
-
-
Weissenbacher, E.R.1
Donders, G.2
Unzeitig, V.3
Martinez De Tejada, B.4
Gerber, S.5
Halaska, M.6
Spacek, J.7
-
224
-
-
79951709246
-
Antimicrobial topical agents used in the vagina
-
Frey Tirri, B. Antimicrobial topical agents used in the vagina. Curr. Probl. Dermatol., 2011, 40, 36-47.
-
(2011)
Curr. Probl. Dermatol.
, vol.40
, pp. 36-47
-
-
Frey Tirri, B.1
-
225
-
-
82255183029
-
Camptothecin (CPT) directly binds to human heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) and inhibits the hnRNP A1/topoisomerase i interaction
-
Manita, D.; Toba, Y.; Takakusagi, Y.; Matsumoto, Y.; Kusayanagi, T.; Takakusagi, K.; Tsukuda, S.; Takada, K.; Kanai, Y.; Kamisuki, S.; Sakaguchi, K.; Sugawara, F. Camptothecin (CPT) directly binds to human heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) and inhibits the hnRNP A1/topoisomerase I interaction. Bioorg. Med. Chem., 2011, 19, 7690-7697.
-
(2011)
Bioorg. Med. Chem.
, vol.19
, pp. 7690-7697
-
-
Manita, D.1
Toba, Y.2
Takakusagi, Y.3
Matsumoto, Y.4
Kusayanagi, T.5
Takakusagi, K.6
Tsukuda, S.7
Takada, K.8
Kanai, Y.9
Kamisuki, S.10
Sakaguchi, K.11
Sugawara, F.12
-
226
-
-
4444358344
-
Camptothecins and topoisomerase I: A foot in the door. Targeting the genome beyond topoisomerase I with camptothecins and novel anticancer drugs: Importance of DNA replication, repair and cell cycle checkpoints
-
DOI 10.2174/1568011043352777
-
Pommier, Y. Camptothecins and topoisomerase I: a foot in the door. Targeting the genome beyond topoisomerase I with camptothecins and novel anticancer drugs: importance of DNA replication, repair and cell cycle checkpoints. Curr. Med. Chem. Anticancer Agents, 2004, 4, 429-434. (Pubitemid 39199346)
-
(2004)
Current Medicinal Chemistry - Anti-Cancer Agents
, vol.4
, Issue.5
, pp. 429-434
-
-
Pommier, Y.1
-
227
-
-
33749034730
-
Topoisomerase I inhibitors: Camptothecins and beyond
-
DOI 10.1038/nrc1977, PII NRC1977
-
Pommier, Y. Topoisomerase I inhibitors: camptothecins and beyond. Nat. Rev. Cancer, 2006, 6, 789-802. (Pubitemid 44450467)
-
(2006)
Nature Reviews Cancer
, vol.6
, Issue.10
, pp. 789-802
-
-
Pommier, Y.1
-
228
-
-
79953839433
-
CRLX101 (formerly IT-101) - A novel nanopharmaceutical of camptothecin in clinical development
-
Young, C.; Schluep, T.; Hwang, J.; Eliasof, S. CRLX101 (formerly IT-101) - a novel nanopharmaceutical of camptothecin in clinical development. Curr. Bioact. Compd., 2011, 7, 8-14.
-
(2011)
Curr. Bioact. Compd.
, vol.7
, pp. 8-14
-
-
Young, C.1
Schluep, T.2
Hwang, J.3
Eliasof, S.4
-
229
-
-
81855169692
-
Antitumor activity of peptide amphiphile nanofiberencapsulated camptothecin
-
Soukasene, S.; Toft, D.J.; Moyer, T.J.; Lu, H.; Lee, H.K.; Standley, S.M.; Cryns, V.L.; Stupp, S.I. Antitumor activity of peptide amphiphile nanofiberencapsulated camptothecin. ACS Nano, 2011, 5, 9113-9121.
-
(2011)
ACS Nano
, vol.5
, pp. 9113-9121
-
-
Soukasene, S.1
Toft, D.J.2
Moyer, T.J.3
Lu, H.4
Lee, H.K.5
Standley, S.M.6
Cryns, V.L.7
Stupp, S.I.8
-
230
-
-
84860542238
-
Preclinical study of the cyclodextrin-polymer conjugate of camptothecin CRLX101 for the treatment of gastric cancer
-
Epub ahead of print
-
Gaur, S.; Chen, L.; Yen, T.; Wang, Y.; Zhou, B.; Davis, M.; Yen, Y. Preclinical study of the cyclodextrin-polymer conjugate of camptothecin CRLX101 for the treatment of gastric cancer. Nanomedicine, 2011, Epub ahead of print.
-
(2011)
Nanomedicine
-
-
Gaur, S.1
Chen, L.2
Yen, T.3
Wang, Y.4
Zhou, B.5
Davis, M.6
Yen, Y.7
-
231
-
-
10444272941
-
Antitumor activity of beta-cyclodextrin polymer-camptothecin conjugates
-
Cheng, J.; Khin, K.T.; Davis, M.E. Antitumor activity of beta-cyclodextrin polymer-camptothecin conjugates. Mol. Pharm., 2004, 1, 183-193.
-
(2004)
Mol. Pharm.
, vol.1
, pp. 183-193
-
-
Cheng, J.1
Khin, K.T.2
Davis, M.E.3
-
232
-
-
57149130657
-
A phase II study of pegylated-camptothecin (pegamotecan) in the treatment of locally advanced and metastatic gastric and gastro-oesophageal junction adenocarcinoma
-
Scott, L.C.; Yao, J.C.; Benson, A.B.; Thomas, A.L.; Falk, S.; Mena, R.R.; Picus, J.; Wright, J.; Mulcahy, M.F.; Ajani, J.A.; Evans, T.R.J. A phase II study of pegylated-camptothecin (pegamotecan) in the treatment of locally advanced and metastatic gastric and gastro-oesophageal junction adenocarcinoma. Cancer Chemother. Pharmacol., 2009, 63, 363-370.
-
(2009)
Cancer Chemother. Pharmacol.
, vol.63
, pp. 363-370
-
-
Scott, L.C.1
Yao, J.C.2
Benson, A.B.3
Thomas, A.L.4
Falk, S.5
Mena, R.R.6
Picus, J.7
Wright, J.8
Mulcahy, M.F.9
Ajani, J.A.10
Evans, T.R.J.11
-
233
-
-
0036399299
-
Camptothecins: A review of their chemotherapeutic potential
-
Ulukan, H.; Swaan, P.W. Camptothecins: a review of their chemotherapeutic potential. Drugs, 2002, 62, 2039-2057. (Pubitemid 35204037)
-
(2002)
Drugs
, vol.62
, Issue.14
, pp. 2039-2057
-
-
Ulukan, H.1
Swaan, P.W.2
-
234
-
-
0036431991
-
Current status and perspectives in the development of camptothecins
-
DOI 10.2174/1381612023392801
-
Zunino, F.; Dallavalleb, S.; Laccabuea, D.; Berettaa, G.; Merlinib, L.; Pratesi, G. Current status and perspectives in the development of camptothecins. Curr. Pharm. Des., 2002, 8, 2505-2520. (Pubitemid 35331535)
-
(2002)
Current Pharmaceutical Design
, vol.8
, Issue.27
, pp. 2505-2520
-
-
Zunino, F.1
Dallavalle, S.2
Laccabue, D.3
Beretta, G.4
Merlini, L.5
Pratesi, G.6
-
235
-
-
80054767978
-
Metabolic activation of irinotecan during intra-arterial chemotherapy of metastatic colorectal cancer
-
Czejka, M.; Kiss, A.; Koessner, C.; Terkola, R.; Ettlinger, D.; Schueller, J. Metabolic activation of irinotecan during intra-arterial chemotherapy of metastatic colorectal cancer. Anticancer Res., 2011, 31, 3573-3578.
-
(2011)
Anticancer Res.
, vol.31
, pp. 3573-3578
-
-
Czejka, M.1
Kiss, A.2
Koessner, C.3
Terkola, R.4
Ettlinger, D.5
Schueller, J.6
-
236
-
-
80052269036
-
Pharmacokinetics of SN2310, an injectable emulsion that incorporates a new derivative of SN-38 in patients with advanced solid tumors
-
Epub ahead of print
-
Marier, J.F.; Pheng, L.; Trinh, M.M.; Burris, H.A.; Jones, S.; Anderson, K.; Warner, S.; Porubek, D. Pharmacokinetics of SN2310, an injectable emulsion that incorporates a new derivative of SN-38 in patients with advanced solid tumors. J. Pharm. Sci., 2011, Epub ahead of print.
-
(2011)
J. Pharm. Sci.
-
-
Marier, J.F.1
Pheng, L.2
Trinh, M.M.3
Burris, H.A.4
Jones, S.5
Anderson, K.6
Warner, S.7
Porubek, D.8
-
237
-
-
70349645655
-
Marked therapeutic efficacy of a novel polyethylene glycol-SN38 conjugate, EZN-2208, in xenograft models of B-cell non-Hodgkin's lymphoma
-
Sapra, P.; Kraft, P.; Mehlig, M.; Malaby, J.; Zhao, H.; Greenberger, L.M.; Horak, I.D. Marked therapeutic efficacy of a novel polyethylene glycol-SN38 conjugate, EZN-2208, in xenograft models of B-cell non-Hodgkin's lymphoma. Haematologica, 2009, 94, 1456-1459.
-
(2009)
Haematologica
, vol.94
, pp. 1456-1459
-
-
Sapra, P.1
Kraft, P.2
Mehlig, M.3
Malaby, J.4
Zhao, H.5
Greenberger, L.M.6
Horak, I.D.7
-
238
-
-
42949130549
-
Novel prodrugs of SN38 using multiarm poly(ethylene glycol) linkers
-
DOI 10.1021/bc700333s
-
Zhao, H.; Rubio, B.; Sapra, P.; Wu, D.; Reddy, P.; Sai, P.; Martinez, A.; Gao, Y.; Lozanguiez, Y.; Longley, C.; Greenberger, L.M.; Horak, I.D. Novel prodrugs of SN38 using multiarm poly(ethylene glycol) linkers. Bioconjug. Chem., 2008, 19, 849-859. (Pubitemid 351614540)
-
(2008)
Bioconjugate Chemistry
, vol.19
, Issue.4
, pp. 849-859
-
-
Zhao, H.1
Rubio, B.2
Sapra, P.3
Wu, D.4
Reddy, P.5
Sai, P.6
Martinez, A.7
Gao, Y.8
Lozanguiez, Y.9
Longley, C.10
Greenberger, L.M.11
Horak, I.D.12
-
239
-
-
41549105038
-
Novel delivery of SN38 markedly inhibits tumor growth in xenografts, including a camptothecin-11-refractory model
-
DOI 10.1158/1078-0432.CCR-07-4456
-
Sapra, P.; Zhao, H.; Mehlig, M.; Malaby, J.; Kraft, P.; Longley, C.; Greenberger, L.M.; Horak, I.D. Novel delivery of SN38 markedly inhibits tumor growth in xenografts, including a camptothecin-11-refractory model. Clin. Cancer Res., 2008, 14, 1888-1896. (Pubitemid 351469476)
-
(2008)
Clinical Cancer Research
, vol.14
, Issue.6
, pp. 1888-1896
-
-
Sapra, P.1
Zhao, H.2
Mehlig, M.3
Malaby, J.4
Kraft, P.5
Longley, C.6
Greenberger, L.M.7
Horak, I.D.8
-
240
-
-
77749264641
-
28th annual JPMorgan healthcare conference - Exelixis and nektar therapeutics
-
Gale, S.; Croasdell, G. 28th Annual JPMorgan Healthcare Conference - Exelixis and Nektar Therapeutics. IDrugs., 2010, 13, 139-141.
-
(2010)
IDrugs.
, vol.13
, pp. 139-141
-
-
Gale, S.1
Croasdell, G.2
-
241
-
-
0346392116
-
Development and characterization of a novel liposome-based formulation of SN-38
-
DOI 10.1016/j.ijpharm.2003.10.015
-
Zhang, J.A.; Xuan, T.; Parmar, M.; Ma, L.; Ugwu, S.; Ali, S.; Ahmad, I. Development and characterization of a novel liposome-based formulation of SN-38. Int. J. Pharm., 2004, 270, 93-107. (Pubitemid 38077091)
-
(2004)
International Journal of Pharmaceutics
, vol.270
, Issue.1-2
, pp. 93-107
-
-
Zhang, J.A.1
Xuan, T.2
Parmar, M.3
Ma, L.4
Ugwu, S.5
Ali, S.6
Ahmad, I.7
-
242
-
-
84857181385
-
Novel molecular targets for the therapy of castration-resistant prostate cancer
-
Epub ahead of print
-
Agarwal, N.; Sonpavde, G.; Sternberg, C.N. Novel molecular targets for the therapy of castration-resistant prostate cancer. Eur. Urol., 2011, Epub ahead of print.
-
(2011)
Eur. Urol.
-
-
Agarwal, N.1
Sonpavde, G.2
Sternberg, C.N.3
-
243
-
-
77952223624
-
Tasquinimod (ABR-215050), a quinoline-3-carboxamide anti-angiogenic agent, modulates the expression of thrombospondin-1 in human prostate tumors
-
Olsson, A.; Bjork, A.; Vallon-Christersson, J.; Isaacs, J.T.; Leanderson, T. Tasquinimod (ABR-215050), a quinoline-3-carboxamide anti-angiogenic agent, modulates the expression of thrombospondin-1 in human prostate tumors. Mol. Cancer, 2010, 9, 107.
-
(2010)
Mol. Cancer
, vol.9
, pp. 107
-
-
Olsson, A.1
Bjork, A.2
Vallon-Christersson, J.3
Isaacs, J.T.4
Leanderson, T.5
-
244
-
-
70349952393
-
Clinical phase i studies of tasquinimod in patients with castration-resistant prostate cancer
-
Bratt, O.; Haggman, M.; Ahlgren, G.; Nordle, O.; Bjork, A.; Damber, J.E. Open-label, clinical phase I studies of tasquinimod in patients with castration-resistant prostate cancer. Br. J. Cancer, 2009, 101, 1233-1240.
-
(2009)
Br. J. Cancer
, vol.101
, pp. 1233-1240
-
-
Bratt, O.1
Haggman, M.2
Ahlgren, G.3
Nordle, O.4
Bjork, A.5
Open-Label, E.D.J.6
-
245
-
-
79959640311
-
Extracts of Canadian first nations medicinal plants, used as natural products, inhibit neisseria gonorrhoeae isolates with different antibiotic resistance profiles
-
Cybulska, P.; Thakur, S.D.; Foster, B.C.; Scott, I.M.; Leduc, R.I.; Arnason, J.T.; Dillon, J.A.R. Extracts of Canadian first nations medicinal plants, used as natural products, inhibit neisseria gonorrhoeae isolates with different antibiotic resistance profiles. Sex. Transm. Dis., 2011, 38, 667-671.
-
(2011)
Sex. Transm. Dis.
, vol.38
, pp. 667-671
-
-
Cybulska, P.1
Thakur, S.D.2
Foster, B.C.3
Scott, I.M.4
Leduc, R.I.5
Arnason, J.T.6
Dillon, J.A.R.7
-
246
-
-
31044440371
-
Antimicrobial activity of berberine alone and in combination with ampicillin or oxacillin against methicillin-resistant Staphylococcus aureus
-
Yu, H.H.; Kim, K.J.; Cha, J.D.; Kim, H.K.; Lee, Y.E.; Choi, N.Y.; You, Y.O. Antimicrobial activity of berberine alone and in combination with ampicillin or oxacillin against methicillin-resistant Staphylococcus aureus. J. Med. Food, 2005, 8, 454-461.
-
(2005)
J. Med. Food
, vol.8
, pp. 454-461
-
-
Yu, H.H.1
Kim, K.J.2
Cha, J.D.3
Kim, H.K.4
Lee, Y.E.5
Choi, N.Y.6
You, Y.O.7
-
247
-
-
36148962372
-
Berberine, a natural isoquinoline alkaloid, induces NAG-1 and ATF3 expression in human colorectal cancer cells
-
DOI 10.1016/j.canlet.2007.09.007, PII S0304383507004375
-
Piyanuch, R.; Sukhthankar, M.; Wandee, G.; Baek, S.J. Berberine, a natural isoquinoline alkaloid, induces NAG-1 and ATF3 expression in human colorectal cancer cells. Cancer Lett., 2007, 258, 230-240. (Pubitemid 350110378)
-
(2007)
Cancer Letters
, vol.258
, Issue.2
, pp. 230-240
-
-
Piyanuch, R.1
Sukhthankar, M.2
Wandee, G.3
Baek, S.J.4
-
248
-
-
36049046675
-
Antiproliferative activity of berberine in vitro and in vivo
-
Letasiova, S.; Jantova, S.; Muckova, M.; Theiszova, M. Antiproliferative activity of berberine in vitro and in vivo. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub., 2005, 149, 461-463.
-
(2005)
Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub.
, vol.149
, pp. 461-463
-
-
Letasiova, S.1
Jantova, S.2
Muckova, M.3
Theiszova, M.4
-
249
-
-
77954383397
-
Effects of nutraceuticals on prevalence of metabolic syndrome and on calculated Framingham Risk Score in individuals with dyslipidemia
-
Izzo, R.; de Simone, G.; Giudice, R.; Chinali, M.; Trimarco, V.; De Luca, N.; Trimarco, B. Effects of nutraceuticals on prevalence of metabolic syndrome and on calculated Framingham Risk Score in individuals with dyslipidemia. J. Hypertens., 2010, 28, 1482-1487.
-
(2010)
J. Hypertens.
, vol.28
, pp. 1482-1487
-
-
Izzo, R.1
De Simone, G.2
Giudice, R.3
Chinali, M.4
Trimarco, V.5
De Luca, N.6
Trimarco, B.7
-
250
-
-
77956589652
-
Berberine: A potential phytochemical with multispectrum therapeutic activities
-
Vuddanda, P.R.; Chakraborty, S.; Singh, S. Berberine: a potential phytochemical with multispectrum therapeutic activities. Expert Opin. Investig. Drugs, 2010, 19, 1297-1307.
-
(2010)
Expert Opin. Investig. Drugs
, vol.19
, pp. 1297-1307
-
-
Vuddanda, P.R.1
Chakraborty, S.2
Singh, S.3
-
251
-
-
79958040988
-
Berberine acutely activates the glucose transport activity of GLUT1
-
Cok, A.; Plaisier, C.; Salie, M.J.; Oram, D.S.; Chenge, J.; Louters, L.L. Berberine acutely activates the glucose transport activity of GLUT1. Biochimie, 2011, 93, 1187-1192.
-
(2011)
Biochimie
, vol.93
, pp. 1187-1192
-
-
Cok, A.1
Plaisier, C.2
Salie, M.J.3
Oram, D.S.4
Chenge, J.5
Louters, L.L.6
-
252
-
-
77954214500
-
Berberine inhibits PTP1B activity and mimics insulin action
-
Chen, C.; Zhang, Y.; Huang, C. Berberine inhibits PTP1B activity and mimics insulin action. Biochem. Biophys. Res. Commun., 2010, 397, 543-547.
-
(2010)
Biochem. Biophys. Res. Commun.
, vol.397
, pp. 543-547
-
-
Chen, C.1
Zhang, Y.2
Huang, C.3
-
253
-
-
79959964544
-
Modulating gut microbiota as an anti-diabetic mechanism of berberine
-
Han, J.; Lin, H.; Huang, W. Modulating gut microbiota as an anti-diabetic mechanism of berberine. Med. Sci. Monit., 2011, 17, RA164-167.
-
(2011)
Med. Sci. Monit.
, vol.17
-
-
Han, J.1
Lin, H.2
Huang, W.3
-
254
-
-
77349115762
-
Berberine:: A plant alkaloid with therapeutic potential for central nervous system disorders
-
Kulkarni, S.K.; Dhir, A. Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders. Phytother. Res., 2010, 24, 317-324.
-
(2010)
Phytother. Res.
, vol.24
, pp. 317-324
-
-
Kulkarni, S.K.1
Dhir, A.2
-
255
-
-
80054777175
-
The therapeutic potential of Berberis darwinii stem-bark: Quantification of berberine and in vitro evidence for Alzheimer's disease therapy
-
Habtemariam, S. The therapeutic potential of Berberis darwinii stem-bark: quantification of berberine and in vitro evidence for Alzheimer's disease therapy. Nat. Prod. Commun., 2011, 6, 1089-1090.
-
(2011)
Nat. Prod. Commun.
, vol.6
, pp. 1089-1090
-
-
Habtemariam, S.1
-
256
-
-
79960135910
-
In vivo and in vitro antiviral effects of berberine on influenza virus
-
Wu, Y.; Li, J.Q.; Kim, Y.J.; Wu, J.; Wang, Q.; Hao, Y. In vivo and in vitro antiviral effects of berberine on influenza virus. Chin. J. Integr. Med., 2011, 17, 444-452.
-
(2011)
Chin. J. Integr. Med.
, vol.17
, pp. 444-452
-
-
Wu, Y.1
Li, J.Q.2
Kim, Y.J.3
Wu, J.4
Wang, Q.5
Hao, Y.6
-
257
-
-
84860523753
-
Vasodilatation produced by Fasudil Mesylate in vivo and in vitro
-
Li, Q.; Chen, Y.; Sun, L.; Fu, G.; Guo, L. Vasodilatation produced by Fasudil Mesylate in vivo and in vitro. Vascul. Pharmacol., 2011, 55, 121-126.
-
(2011)
Vascul. Pharmacol.
, vol.55
, pp. 121-126
-
-
Li, Q.1
Chen, Y.2
Sun, L.3
Fu, G.4
Guo, L.5
-
258
-
-
80052966594
-
Rho-associated kinase activity, endothelial function, and cardiovascular risk factors
-
Soga, J.; Noma, K.; Hata, T.; Hidaka, T.; Fujii, Y.; Idei, N.; Fujimura, N.; Mikami, S.; Maruhashi, T.; Kihara, Y.; Chayama, K.; Kato, H.; Liao, J.K.; Higashi, Y. Rho-associated kinase activity, endothelial function, and cardiovascular risk factors. Arterioscler. Thromb. Vasc. Biol., 2011, 31, 2353-2359.
-
(2011)
Arterioscler. Thromb. Vasc. Biol.
, vol.31
, pp. 2353-2359
-
-
Soga, J.1
Noma, K.2
Hata, T.3
Hidaka, T.4
Fujii, Y.5
Idei, N.6
Fujimura, N.7
Mikami, S.8
Maruhashi, T.9
Kihara, Y.10
Chayama, K.11
Kato, H.12
Liao, J.K.13
Higashi, Y.14
-
259
-
-
79960792540
-
Recent progress in the management of pulmonary hypertension
-
Fukumoto, Y.; Shimokawa, H. Recent progress in the management of pulmonary hypertension. Circ. J., 2011, 75, 1801-1810.
-
(2011)
Circ. J.
, vol.75
, pp. 1801-1810
-
-
Fukumoto, Y.1
Shimokawa, H.2
-
260
-
-
79961067803
-
Rho-kinase: Important new therapeutic target in cardiovascular diseases
-
Satoh, K.; Fukumoto, Y.; Shimokawa, H. Rho-kinase: important new therapeutic target in cardiovascular diseases. Am. J. Physiol. Heart Circ. Physiol., 2011, 301, H287-296.
-
(2011)
Am. J. Physiol. Heart Circ. Physiol.
, vol.301
-
-
Satoh, K.1
Fukumoto, Y.2
Shimokawa, H.3
-
261
-
-
0040029094
-
Raynaud's phenomenon
-
O'Connor, C.M. Raynaud's phenomenon. J. Vasc. Nurs., 2001, 19, 87-92.
-
(2001)
J. Vasc. Nurs.
, vol.19
, pp. 87-92
-
-
O'connor, C.M.1
-
262
-
-
54549092672
-
Treatment of Raynaud's phenomenon
-
Garcia-Carrasco, M.; Jimenez-Hernandez, M.; Escarcega, R. O.; Mendoza-Pinto, C.; Pardo-Santos, R.; Levy, R.; Maldonado, C.G.; Chavez, G.P.; Cervera, R. Treatment of Raynaud's phenomenon. Autoimmun. Rev., 2008, 8, 62-68.
-
(2008)
Autoimmun. Rev.
, vol.8
, pp. 62-68
-
-
Garcia-Carrasco, M.1
Jimenez-Hernandez, M.2
Escarcega, R.O.3
Mendoza-Pinto, C.4
Pardo-Santos, R.5
Levy, R.6
Maldonado, C.G.7
Chavez, G.P.8
Cervera, R.9
-
263
-
-
33644794902
-
Cardioprotective effect of hydroxyfasudil as a specific Rho-kinase inhibitor, on ischemia-reperfusion injury in canine coronary microvessels in vivo
-
Yada, T.; Shimokawa, H.; Kajiya, F. Cardioprotective effect of hydroxyfasudil as a specific Rho-kinase inhibitor, on ischemia-reperfusion injury in canine coronary microvessels in vivo. Clin. Hemorheol. Microcirc., 2006, 34, 177-183. (Pubitemid 43351027)
-
(2006)
Clinical Hemorheology and Microcirculation
, vol.34
, Issue.1-2
, pp. 177-183
-
-
Yada, T.1
Shimokawa, H.2
Kajiya, F.3
-
264
-
-
60549103537
-
Peripheral delivery of a ROCK inhibitor improves learning and working memory
-
Huentelman, M.J.; Stephan, D.A.; Talboom, J.; Corneveaux, J.J.; Reiman, D.M.; Gerber, J.D.; Barnes, C.A.; Alexander, G.E.; Reiman, E.M.; Bimonte-Nelson, H.A. Peripheral delivery of a ROCK inhibitor improves learning and working memory. Behav. Neurosci., 2009, 123, 218-223.
-
(2009)
Behav. Neurosci.
, vol.123
, pp. 218-223
-
-
Huentelman, M.J.1
Stephan, D.A.2
Talboom, J.3
Corneveaux, J.J.4
Reiman, D.M.5
Gerber, J.D.6
Barnes, C.A.7
Alexander, G.E.8
Reiman, E.M.9
Bimonte-Nelson, H.A.10
-
265
-
-
84855837715
-
Sotrastaurin: A new selective protein kinase C inhibitor, on the way
-
Yamashita, K.; Todo, S. Sotrastaurin, a new selective protein kinase C inhibitor, on the way. Transplantation, 2011, 93, 146-147.
-
(2011)
Transplantation
, vol.93
, pp. 146-147
-
-
Yamashita, K.1
Todo, S.2
-
266
-
-
70349128209
-
The potent protein kinase Cselective inhibitor AEB071 (sotrastaurin) represents a new class of immunosuppressive agents affecting early T-cell activation
-
Evenou, J.P.; Wagner, J.; Zenke, G.; Brinkmann, V.; Wagner, K.; Kovarik, J.; Welzenbach, K.A; Weitz-Schmidt, G.; Guntermann, C.; Towbin, H.; Cottens, S.; Kaminski, S.; Letschka, T.; Lutz-Nicoladoni, C.; Gruber, T.; Hermann-Kleiter, N.; Thuille, N.; Baier, G. The potent protein kinase Cselective inhibitor AEB071 (sotrastaurin) represents a new class of immunosuppressive agents affecting early T-cell activation. J. Pharmacol. Exp. Ther., 2009, 330, 792-801.
-
(2009)
J. Pharmacol. Exp. Ther.
, vol.330
, pp. 792-801
-
-
Evenou, J.P.1
Wagner, J.2
Zenke, G.3
Brinkmann, V.4
Wagner, K.5
Kovarik, J.6
Welzenbach, K.A.7
Weitz-Schmidt, G.8
Guntermann, C.9
Towbin, H.10
Cottens, S.11
Kaminski, S.12
Letschka, T.13
Lutz-Nicoladoni, C.14
Gruber, T.15
Hermann-Kleiter, N.16
Thuille, N.17
Baier, G.18
-
267
-
-
79959832380
-
Sotrastaurin: A novel small molecule inhibiting protein-kinase C: Randomized phase II study in renal transplant recipients
-
Friman, S.; Arns, W.; Nashan, B.; Vincenti, F.; Banas, B.; Budde, K.; Cibrik, D.; Chan, L.; Klempnauer, J.; Mulgaonkar, S.; Nicholson, M.; Wahlberg, J.; Wissing, K.M.; Abrams, K.; Witte, S.; Woodle, E.S. Sotrastaurin, a novel small molecule inhibiting protein-kinase C: randomized phase II study in renal transplant recipients. Am. J. Transplant., 2011, 11, 1444-1455.
-
(2011)
Am. J. Transplant.
, vol.11
, pp. 1444-1455
-
-
Friman, S.1
Arns, W.2
Nashan, B.3
Vincenti, F.4
Banas, B.5
Budde, K.6
Cibrik, D.7
Chan, L.8
Klempnauer, J.9
Mulgaonkar, S.10
Nicholson, M.11
Wahlberg, J.12
Wissing, K.M.13
Abrams, K.14
Witte, S.15
Woodle, E.S.16
-
268
-
-
79551545338
-
Sotrastaurin single-dose pharmacokinetics in de novo liver transplant recipients
-
Kovarik, J.M.; Neuhaus, P.; Cillo, U.; Weber, M.; Stitah, S.; Gatlik, E.; Meiser, K.; Slade, A. Sotrastaurin single-dose pharmacokinetics in de novo liver transplant recipients. Transpl. Int., 2011, 24, 276-283.
-
(2011)
Transpl. Int.
, vol.24
, pp. 276-283
-
-
Kovarik, J.M.1
Neuhaus, P.2
Cillo, U.3
Weber, M.4
Stitah, S.5
Gatlik, E.6
Meiser, K.7
Slade, A.8
-
269
-
-
80052418719
-
The novel immunosuppressive protein kinase C inhibitor sotrastaurin has no pro-viral effects on the replication cycle of hepatitis B or C virus
-
von Hahn, T.; Schulze, A.; Chicano Wust, I.; Heidrich, B.; Becker, T.; Steinmann, E.; Helfritz, F.A; Rohrmann, K.; Urban, S.; Manns, M. P.; Pietschmann, T.; Ciesek, S. The novel immunosuppressive protein kinase C inhibitor sotrastaurin has no pro-viral effects on the replication cycle of hepatitis B or C virus. PloS One, 2011, 6, e24142.
-
(2011)
PloS One
, vol.6
-
-
Von Hahn, T.1
Schulze, A.2
Chicano Wust, I.3
Heidrich, B.4
Becker, T.5
Steinmann, E.6
Helfritz, F.A.7
Rohrmann, K.8
Urban, S.9
Manns, M.P.10
Pietschmann, T.11
Ciesek, S.12
-
270
-
-
79956012866
-
Assessing the activity of cediranib, a VEGFR-2/3 tyrosine kinase inhibitor, against VEGFR-1 and members of the structurally related PDGFR family
-
Brave, S.R.; Ratcliffe, K.; Wilson, Z.; James, N.H.; Ashton, S.; Wainwright, A.; Kendrew, J.; Dudley, P.; Broadbent, N.; Sproat, G.; Taylor, S.; Barnes, C.; Silva, J.C.; Farnsworth, C.L.; Hennequin, L.; Ogilvie, D.J.; Jurgensmeier, J.M.; Shibuya, M.; Wedge, S.R.; Barry, S.T. Assessing the activity of cediranib, a VEGFR-2/3 tyrosine kinase inhibitor, against VEGFR-1 and members of the structurally related PDGFR family. Mol. Cancer Ther., 2011, 10, 861-873.
-
(2011)
Mol. Cancer Ther.
, vol.10
, pp. 861-873
-
-
Brave, S.R.1
Ratcliffe, K.2
Wilson, Z.3
James, N.H.4
Ashton, S.5
Wainwright, A.6
Kendrew, J.7
Dudley, P.8
Broadbent, N.9
Sproat, G.10
Taylor, S.11
Barnes, C.12
Silva, J.C.13
Farnsworth, C.L.14
Hennequin, L.15
Ogilvie, D.J.16
Jurgensmeier, J.M.17
Shibuya, M.18
Wedge, S.R.19
Barry, S.T.20
more..
-
271
-
-
80054715969
-
A two-part phase II study of cediranib in patients with advanced solid tumours: The effect of food on single-dose pharmacokinetics and an evaluation of safety, efficacy and imaging pharmacodynamics
-
Mitchell, C.L.; O'Connor, J.P.B.; Roberts, C.; Watson, Y.; Jackson, A.; Cheung, S.; Evans, J.; Spicer, J.; Harris, A.; Kelly, C.; Rudman, S.; Middleton, M.; Fielding, A.; Tessier, J.; Young, H.; Parker, G.J.M.; Jayson, G.C. A two-part phase II study of cediranib in patients with advanced solid tumours: the effect of food on single-dose pharmacokinetics and an evaluation of safety, efficacy and imaging pharmacodynamics. Cancer Chemother. Pharmacol., 2011, 68, 631-641.
-
(2011)
Cancer Chemother. Pharmacol.
, vol.68
, pp. 631-641
-
-
Mitchell, C.L.1
O'connor, J.P.B.2
Roberts, C.3
Watson, Y.4
Jackson, A.5
Cheung, S.6
Evans, J.7
Spicer, J.8
Harris, A.9
Kelly, C.10
Rudman, S.11
Middleton, M.12
Fielding, A.13
Tessier, J.14
Young, H.15
Parker, G.J.M.16
Jayson, G.C.17
-
272
-
-
78650070633
-
Phase II trials of single-agent anti-VEGF therapy for patients with chronic lymphocytic leukemia
-
Shanafelt, T.; Zent, C.; Byrd, J.; Erlichman, C.; Laplant, B.; Ghosh, A.; Call, T.; Villalona-Calero, M.; Jelinek, D.; Bowen, D.; Laumann, K.; Wu, W.; Hanson, C.; Kay, N. Phase II trials of single-agent anti-VEGF therapy for patients with chronic lymphocytic leukemia. Leuk. Lymphoma, 2010, 51, 2222-2229.
-
(2010)
Leuk. Lymphoma
, vol.51
, pp. 2222-2229
-
-
Shanafelt, T.1
Zent, C.2
Byrd, J.3
Erlichman, C.4
Laplant, B.5
Ghosh, A.6
Call, T.7
Villalona-Calero, M.8
Jelinek, D.9
Bowen, D.10
Laumann, K.11
Wu, W.12
Hanson, C.13
Kay, N.14
-
273
-
-
84856065097
-
Cediranib in combination with various anticancer regimens: Results of a phase i multi-cohort study
-
Lorusso, P.; Shields, A.F.; Gadgeel, S.; Vaishampayan, U.; Guthrie, T.; Puchalski, T.; Xu, J.; Liu, Q. Cediranib in combination with various anticancer regimens: results of a phase I multi-cohort study. Invest. New Drugs, 2011, 29, 1395-1405.
-
(2011)
Invest. New Drugs
, vol.29
, pp. 1395-1405
-
-
Lorusso, P.1
Shields, A.F.2
Gadgeel, S.3
Vaishampayan, U.4
Guthrie, T.5
Puchalski, T.6
Xu, J.7
Liu, Q.8
-
274
-
-
77955094938
-
Phase II study of Cediranib (AZD 2171), an inhibitor of the vascular endothelial growth factor receptor, for second-line therapy of small cell lung cancer (National Cancer Institute #7097)
-
Ramalingam, S.S.; Belani, C.P.; Mack, P.C.; Vokes, E.E.; Longmate, J.; Govindan, R.; Koczywas, M.; Ivy, S.P.; Gandara, D.R. Phase II study of Cediranib (AZD 2171), an inhibitor of the vascular endothelial growth factor receptor, for second-line therapy of small cell lung cancer (National Cancer Institute #7097). J. Thorac. Oncol., 2010, 5, 1279-1284.
-
(2010)
J. Thorac. Oncol.
, vol.5
, pp. 1279-1284
-
-
Ramalingam, S.S.1
Belani, C.P.2
MacK, P.C.3
Vokes, E.E.4
Longmate, J.5
Govindan, R.6
Koczywas, M.7
Ivy, S.P.8
Gandara, D.R.9
-
275
-
-
84860510667
-
Cediranib inhibits both the intraosseous growth of PDGF D-Positive prostate cancer cells and the associated bone reaction
-
Epub ahead of print
-
Najy, A.J.; Jung, Y.S.; Won, J.J.; Conley-Lacomb, M.K.; Saliganan, A.; Kim, C.J.; Heath, E.; Cher, M.L.; Bonfil, R.D.; Kim, H.R.C. Cediranib inhibits both the intraosseous growth of PDGF D-Positive prostate cancer cells and the associated bone reaction. Prostate, 2011, Epub ahead of print.
-
(2011)
Prostate
-
-
Najy, A.J.1
Jung, Y.S.2
Won, J.J.3
Conley-Lacomb, M.K.4
Saliganan, A.5
Kim, C.J.6
Heath, E.7
Cher, M.L.8
Bonfil, R.D.9
Kim, H.R.C.10
-
276
-
-
78651408563
-
Glioblastoma recurrence after cediranib therapy in patients: Lack of "rebound" revascularization as mode of escape
-
di Tomaso, E.; Snuderl, M.; Kamoun, W.S.; Duda, D.G.; Auluck, P.K.; Fazlollahi, L.; Andronesi, O.C.; Frosch, M.P.; Wen, P.Y.; Plotkin, S.R.; Hedley-Whyte, E.T.; Sorensen, A.G.; Batchelor, T.T.; Jain, R.K. Glioblastoma recurrence after cediranib therapy in patients: lack of "rebound" revascularization as mode of escape. Cancer Res., 2011, 71, 19-28.
-
(2011)
Cancer Res.
, vol.71
, pp. 19-28
-
-
Di Tomaso, E.1
Snuderl, M.2
Kamoun, W.S.3
Duda, D.G.4
Auluck, P.K.5
Fazlollahi, L.6
Andronesi, O.C.7
Frosch, M.P.8
Wen, P.Y.9
Plotkin, S.R.10
Hedley-Whyte, E.T.11
Sorensen, A.G.12
Batchelor, T.T.13
Jain, R.K.14
-
277
-
-
84856509572
-
Phase i study to assess the safety and tolerability of olaparib in combination with bevacizumab in patients with advanced solid tumours
-
Dean, E.; Middleton, M.R.; Pwint, T.; Swaisland, H.; Carmichael, J.; Goodege-Kunwar, P.; Ranson, M. Phase I study to assess the safety and tolerability of olaparib in combination with bevacizumab in patients with advanced solid tumours. Br. J. Cancer, 2012, 106, 468-474.
-
(2012)
Br. J. Cancer
, vol.106
, pp. 468-474
-
-
Dean, E.1
Middleton, M.R.2
Pwint, T.3
Swaisland, H.4
Carmichael, J.5
Goodege-Kunwar, P.6
Ranson, M.7
-
278
-
-
80054869232
-
PARP inhibitors-current status and the walk towards early breast cancer
-
Glendenning, J.; Tutt, A. PARP inhibitors-current status and the walk towards early breast cancer. Breast., 2011, 20 Suppl 3, S12-19.
-
(2011)
Breast.
, vol.20 SUPPL. 3
-
-
Glendenning, J.1
Tutt, A.2
-
279
-
-
0033198919
-
Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions
-
DOI 10.1042/0264-6021:3420249
-
D'Amours, D.; Desnoyers, S.; D'Silva, I.; Poirier, G.G. Poly(ADPribosyl) ation reactions in the regulation of nuclear functions. Biochem. J., 1999, 342, 249-268. (Pubitemid 29425344)
-
(1999)
Biochemical Journal
, vol.342
, Issue.2
, pp. 249-268
-
-
D'Amours, D.1
Desnoyers, S.2
D'Silva, I.3
Poirier, G.G.4
-
280
-
-
0032842477
-
Functions of poly(ADP-ribose) polymerase in controlling telomere length and chromosomal stability
-
DOI 10.1038/12680
-
d'Adda di Fagagna, F.; Hande, M.P.; Tong, W.M.; Lansdorp, P.M.; Wang, Z.Q.; Jackson, S.P. Functions of poly(ADP-ribose) polymerase in controlling telomere length and chromosomal stability. Nat. Genet., 1999, 23, 76-80. (Pubitemid 29418792)
-
(1999)
Nature Genetics
, vol.23
, Issue.1
, pp. 76-80
-
-
Di Fagagna, F.D.1
Hande, M.P.2
Tong, W.-M.3
Lansdorp, P.M.4
Wang, Z.-Q.5
Jackson, S.P.6
-
281
-
-
4544374528
-
BRCA1 and BRCA2: 1994 and beyond
-
DOI 10.1038/nrc1431
-
Narod, S.A.; Foulkes, W.D. BRCA1 and BRCA2: 1994 and beyond. Nat. Rev. Cancer, 2004, 4, 665-676. (Pubitemid 39215065)
-
(2004)
Nature Reviews Cancer
, vol.4
, Issue.9
, pp. 665-676
-
-
Narod, S.A.1
Foulkes, W.D.2
-
282
-
-
77951445939
-
Poly(adp-ribose) polymerase inhibitors: A novel drug class with a promising future
-
Gartner, E.M.; Burger, A.M.; Lorusso, P.M. Poly(adp-ribose) polymerase inhibitors: a novel drug class with a promising future. Cancer J., 2010, 16, 83-90.
-
(2010)
Cancer J.
, vol.16
, pp. 83-90
-
-
Gartner, E.M.1
Burger, A.M.2
Lorusso, P.M.3
-
283
-
-
79952281417
-
A phase i study of the safety and tolerability of olaparib (AZD2281, KU0059436) and dacarbazine in patients with advanced solid tumours
-
Khan, O.A.; Gore, M.; Lorigan, P.; Stone, J.; Greystoke, A.; Burke, W.; Carmichael, J.; Watson, A.J.; McGown, G.; Thorncroft, M.; Margison, G.P.; Califano, R.; Larkin, J.; Wellman, S.; Middleton, M.R. A phase I study of the safety and tolerability of olaparib (AZD2281, KU0059436) and dacarbazine in patients with advanced solid tumours. Br. J. Cancer, 2011, 104, 750-755.
-
(2011)
Br. J. Cancer
, vol.104
, pp. 750-755
-
-
Khan, O.A.1
Gore, M.2
Lorigan, P.3
Stone, J.4
Greystoke, A.5
Burke, W.6
Carmichael, J.7
Watson, A.J.8
McGown, G.9
Thorncroft, M.10
Margison, G.P.11
Califano, R.12
Larkin, J.13
Wellman, S.14
Middleton, M.R.15
-
284
-
-
67650471685
-
Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers
-
Fong, P.C.; Boss, D.S.; Yap, T.A.; Tutt, A.; Wu, P.; Mergui-Roelvink, M.; Mortimer, P.; Swaisland, H.; Lau, A.; O'Connor, M.J.; Ashworth, A.; Carmichael, J.; Kaye, S.B.; Schellens, J.H.M.; de Bono, J.S. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N. Engl. J. Med., 2009, 361, 123-134.
-
(2009)
N. Engl. J. Med.
, vol.361
, pp. 123-134
-
-
Fong, P.C.1
Boss, D.S.2
Yap, T.A.3
Tutt, A.4
Wu, P.5
Mergui-Roelvink, M.6
Mortimer, P.7
Swaisland, H.8
Lau, A.9
O'connor, M.J.10
Ashworth, A.11
Carmichael, J.12
Kaye, S.B.13
Schellens, J.H.M.14
De Bono, J.S.15
-
285
-
-
80052389761
-
Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: A phase 2, multicentre, open-label, nonrandomised study
-
Gelmon, K.A.; Tischkowitz, M.; Mackay, H.; Swenerton, K.; Robidoux, A.; Tonkin, K.; Hirte, H.; Huntsman, D.; Clemons, M.; Gilks, B.; Yerushalmi, R.; Macpherson, E.; Carmichael, J.; Oza, A. Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, nonrandomised study. Lancet Oncol., 2011, 12, 852-861.
-
(2011)
Lancet Oncol.
, vol.12
, pp. 852-861
-
-
Gelmon, K.A.1
Tischkowitz, M.2
MacKay, H.3
Swenerton, K.4
Robidoux, A.5
Tonkin, K.6
Hirte, H.7
Huntsman, D.8
Clemons, M.9
Gilks, B.10
Yerushalmi, R.11
MacPherson, E.12
Carmichael, J.13
Oza, A.14
-
286
-
-
77955039099
-
Oral poly(ADPribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: A proof-of-concept trial
-
Audeh, M.W.; Carmichael, J.; Penson, R.T.; Friedlander, M.; Powell, B.; Bell-McGuinn, K.M.; Scott, C.; Weitzel, J.N.; Oaknin, A.; Loman, N.; Lu, K.; Schmutzler, R.K.; Matulonis, U.; Wickens, M.; Tutt, A. Oral poly(ADPribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial. Lancet, 2010, 376, 245-251.
-
(2010)
Lancet
, vol.376
, pp. 245-251
-
-
Audeh, M.W.1
Carmichael, J.2
Penson, R.T.3
Friedlander, M.4
Powell, B.5
Bell-Mcguinn, K.M.6
Scott, C.7
Weitzel, J.N.8
Oaknin, A.9
Loman, N.10
Lu, K.11
Schmutzler, R.K.12
Matulonis, U.13
Wickens, M.14
Tutt, A.15
-
287
-
-
79952596805
-
PARP inhibitors in oncology: A new synthetic lethal approach to cancer therapy
-
Kruse, V.; Rottey, S.; De Backer, O.; Van Belle, S.; Cocquyt, V.; Denys, H. PARP inhibitors in oncology: a new synthetic lethal approach to cancer therapy. Acta Clin. Belg., 2011, 66, 2-9.
-
(2011)
Acta Clin. Belg.
, vol.66
, pp. 2-9
-
-
Kruse, V.1
Rottey, S.2
De Backer, O.3
Van Belle, S.4
Cocquyt, V.5
Denys, H.6
|